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 ABSTRACT 
 
Important bidirectional interactions exist between the central nervous system and the 
immune system.  Neural-immune interactions provide a regulatory system in the body and 
disturbances in these interactions may lead to disease. Although the sympathetic nervous system 
is thought to play a key role in mediating neural-immune interactions, central neural mechanisms 
mediating sympathetic-immune interactions and the effect of centrally-induced alterations in 
sympathetic nerve discharge on immune function is not known. We tested the hypothesis that 
central activation of sympathetic neural circuits alters splenic cytokine gene expression. In a 
separate study, we tested the hypothesis that hypothermia-induced changes in visceral 
sympathetic nerve discharge (SND) would be attenuated in middle-aged and aged compared with 
young rats. Previous studies have demonstrated that skin sympathoexcitatory responses to skin 
cooling are attenuated in aged compared with young subjects, suggesting that advancing age 
influences sympathetic nerve responsiveness to cooling. The effect of age on sympathetic nerves 
innervating other targets organs during acute cooling remains unknown.  Central activation of 
splenic SND was produced using three different experimental interventions: increased core body 
temperature produced by acute heating, intracerebroventricular injection of angiotensin II (ANG 
II), and decreased core body temperature produced by acute cooling. Changes in gene expression 
profiles were analyzed using inflammatory cytokine-specific gene-array and further validated 
using real-time RT-PCR analysis. The following observations were made. 1) Splenic SND 
increased in response to each experimental intervention except in acute cooled young rats where 
there was a decrease in splenic SND. 2) Splenic cytokine gene expression of pro-inflammatory 
cytokines (e.g., IL-1β, IL-6, IL-2) and chemokines (GRO1, CXCL2, CCCL2 and, CXCL10) was 
increased in response to each experimental intervention. 3) Expression of splenic cytokine genes 
was reduced after splenic-denervation except in acute cooled rats. 4) Progressive hypothermia 
reduced splenic, renal, and adrenal SND in rats and was generally attenuated in middle-aged and 
aged rats. These results demonstrate the functional significance of changes in sympathetic nerve 
activity on splenic immune cell activation and the effect of age on SND responses to core body 
cooling. 
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ABSTRACT  
 
Whole body hyperthermia (WBH) has been used in experimental settings as an adjunct to 
radio-chemotherapy for the treatment of various malignant diseases.  The therapeutic effect of 
WBH has been hypothesized to involve activation of the immune system, although the effect of 
hyperthermia-induced activation of sympathetic nerve discharge (SND) on splenic immune 
function is not known.  We tested the hypothesis that heating-induced splenic 
sympathoexcitation would alter splenic cytokine gene expression as determined using gene array 
and real-time RT-PCR analyses.  Experiments were performed in splenic-intact and splenic-
denervated anesthetized Sprague-Dawley rats (n = 32).  Splenic SND was increased during 
heating (internal temperature increased from 38o to 41oC) in splenic-intact rats but remained 
unchanged in nonheated splenic-intact rats.  Splenic interleukin-1β (IL-1β), interleukin-6 (IL-6), 
and growth regulated oncogene 1 (GRO 1) mRNA expression was higher in heated than in 
nonheated splenic-intact rats.  Splenic IL-1β, IL-6, and GRO 1 mRNA expression was reduced in 
heated splenic-denervated compared with heated splenic-intact rats, but did not differ between 
heated splenic-denervated and nonheated splenic-intact rats.  These results support the 
hypothesis that hyperthermia-induced activation of splenic SND enhances splenic cytokine gene 
expression.   
Key words: Whole body hyperthermia; Splenic SND; Splenc cytokine gene expression 
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INTRODUCTION 
Whole body hyperthermia (WBH) profoundly influences sympathetic nerve regulation. 
Increased internal body temperature produced by whole body heating increases muscle 
sympathetic nerve discharge (SND) in conscious humans (10-12, 50), splanchnic SND in 
conscious rats (36), and renal, splanchnic, and splenic sympathetic nerve activity in anesthetized 
rats (22, 29-31, 33) and decreases SND directed to the caudal ventral artery in the rat (27).  
Moreover, moderate body warming decreases skin sympathetic nerve activity in human subjects 
(13).  Hyperthermia-induced increases in visceral SND are attenuated during acute heating in 
cervical transected rats (33), supporting an important role for supraspinal neural circuits in 
mediating visceral sympathetic nerve responses to increased internal body temperature. 
WBH has been used in experimental settings as an adjunct to radio-chemotherapy for the 
treatment of various malignant diseases (20, 58).  The therapeutic effect of WBH in these 
conditions has been hypothesized to involve activation of the immune system (5, 51, 52).  Robins 
et al. (52) reported elevated plasma levels of granulocyte-colony stimulating factor, interleukin-
1β (IL-1β), interleukin-6 (IL-6), interleukin-8, interleukin-10, and tumor necrosis factor-α (TNF-
α) when WBH was used in conjunction with chemotherapy in human patients.  Atanackovic et 
al. (5) reported that human patients receiving WBH along with chemotherapy demonstrated 
immediate and significant increases in peripheral natural killer cells, CD56+ cytotoxic T 
lymphocytes, and serum concentrations of IL-6 and TNF-α, changes that were not observed in 
patients receiving chemotherapy alone.  These results support the hypothesis that WBH provides 
a stimulus to the immune system.    
The sympathetic nervous system, along with cytokines and the hypothalamic-pituitary-
adrenal axis, is thought to play an important role in mediating bidirectional neural-immune 
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interactions (1, 2, 14, 46).  A role for the sympathetic nervous system in immune regulation is 
supported by the innervation of lymphoid organs (including the spleen) by sympathetic nerves 
(15-19) and the presence of adrenergic receptors on immune cells (8, 34, 39, 42, 48).  A role for 
the immune system in sympathetic nerve regulation is supported by the increased rate of 
norepinephrine release and turnover in spleen and bone marrow following activation of antigen-
specific T cells and B cells by a soluble protein antigen (35) and changes in the level of SND 
produced by administration of IL-1β antibody (43) and IL-1β (25, 56).  As reviewed by Madden 
(45), complex functional interactions exist between the sympathetic nervous system and the 
immune system and it has been shown that the sympathetic nervous system can both enhance 
and inhibit immune responses, depending on experimental conditions, the type of stress 
paradigm used, activation state of the sympathetic nervous system, and types of immune cells 
activated.  In addition, immune cell products can influence the functional state of the sympathetic 
nervous system.  For example, Rogausch et al. (53, 54, 55) have demonstrated that locally 
produced IL-1β inhibits the release of norepinephrine from postganglionic splenic sympathetic 
nerves which in turn leads to an increase in splenic blood flow.   
Although sympathetic nerves are considered an important component of the 
communication pathway between the brain and the immune system, the influence of 
hyperthermia-induced activation of splenic sympathetic nerve outflow on splenic immune 
function remains poorly defined.  In the present study we determined the effect of WBH on 
splenic SND and splenic cytokine gene expression in urethane-chloralose anesthetized rats.  
Because the sympathetic innervation of the spleen provides a direct link between central 
sympathetic neural circuits and immunocompetent cells in the spleen (15, 19), we tested the 
hypothesis that hyperthermia-induced activation of splenic SND would alter splenic cytokine 
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gene expression as determined using gene array and real-time RT-PCR analyses.  To 
demonstrate a role for the sympathetic nervous system in mediating splenic cytokine gene 
expression responses to WBH, experiments were completed in splenic-intact and splenic-
denervated rats.  The current study provides new findings supporting the idea that hyperthermia-
induced activation of splenic SND enhances splenic cytokine gene expression. 
 
METHODS 
General procedures.  The Institutional Animal Care and Use Committee approved the 
experimental procedures and protocols used in the present study and all procedures were 
performed in accordance with the American Physiological Society’s guiding principles for 
research involving animals (3).  Experiments were performed on Sprague-Dawley rats (381 ± 6 
g, n = 32).  Anesthesia was induced by isoflurane (3%) and maintained during surgical 
procedures using isoflurane (1.5%), α-chloralose (80 mg/kg, ip), and urethane (800 mg/kg, ip) 
(31, 32, 43).  During the experimental protocol, maintenance doses of α-chloralose were infused 
intravenously (femoral vein, 35-45 mg/kg/hr).  The trachea was cannulated with a polyethylene-
240 catheter.  Femoral arterial pressure was monitored using a pressure transducer connected to a 
blood pressure analyzer.  Heart rate (HR) was derived from the pulsatile arterial pressure output 
of the blood pressure analyzer.  Colonic temperature (Tc) was measured with a thermistor probe 
inserted approximately 5 cm into the colon.  Tc was maintained between 37.8оC and 38.0оC 
during surgical procedures by a homeothermic blanket. 
Neural recordings.  Splenic sympathetic nerve activity was recorded biphasically with a 
platinum bipolar electrode after preamplification (bandpass 30-3,000 Hz).  In splenic-denervated 
rats, renal sympathetic nerve activity was recorded using similar recording and preamplification 
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procedures.  Using a lateral approach, splenic and renal sympathetic nerves were dissected free 
of surrounding connective tissue and isolated.  Nerve-electrode preparations were covered with 
silicone gel.  The filtered neurograms were routed to an oscilloscope and a nerve traffic analyzer 
for monitoring during the experiment and for subsequent data analysis.  Sympathetic nerve 
potentials were full-wave rectified, integrated (time constant 10 ms) and quantified as volts x 
seconds (V·s) (29-31, 33).  The level of activity in sympathetic nerves was corrected for 
background noise after administration of the ganglionic blocker trimethaphan camsylate (10-15 
mg/kg iv).    
Splenic denervation.  A two-step denervation procedure was performed.  Initially, the 
splenic bundle (including the splenic artery, vein and nerve) was visualized using a lateral 
approach and the splenic nerve was dissected free of surrounding connective tissue and sectioned 
at the base of the bundle.  Subsequently in the same operation, the individual arteries projecting 
to the spleen were identified and the sympathetic nerve adjoining each vessel was sectioned.  
Denervation was considered complete when splenic nerve recordings taken at a site distal to the 
lesions demonstrated no sympathetic nerve activity.   
Splenic blood flow determination.  Catheters were placed in the right carotid artery and 
the femoral artery.  The right carotid artery catheter was advanced towards the heart and secured 
in position just inside the aortic arch.  The femoral artery catheter was advanced towards the 
descending aorta and secured in place.  The carotid catheter was connected to a pressure 
transducer and femoral artery catheter was connected to a 1 ml syringe placed in a Harvard 
withdrawal pump.  For each blood flow determination, blood withdrawal from the femoral artery 
catheter was initiated at a rate of 0.25 ml/min.  At the same time, arterial blood pressure was 
recorded from the carotid artery catheter.  After 30 seconds of blood withdrawal, the carotid 
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artery catheter was disconnected from the pressure transducer and radioactive microspheres were 
injected into the aortic arch.  Labeled microspheres were 15±3 µm in diameter.  The 
microspheres were suspended in normal saline containing 0.01% Tween 80 with a specific 
activity ranging from 7-15 mCi/g.  Before each injection, the microspheres 6-7 x 105 were 
thoroughly mixed and agitated by sonication to prevent clumping.  Microspheres were injected 
into the ascending aorta in a volume of approximately 0.10 ml and the different radioactive 
labels (46Sc, 85Sr, 113Sn, and 141Ce) were used in random order.  At the end of each experiment, 
the rat was killed with an overdose of methohexital sodium (150 mg/kg iv).  The placement of 
each catheter was verified by anatomical dissection.   
Spleens and kidneys were removed, blotted, weighed and placed immediately into 
counting vials.  The radioactivity of tissue samples was determined on a Packard Cobra II Auto-
Gamma Spectrometer set to record the peak energy activity of each isotope for 5 min, and 
analyzed by computer, taking into account the cross-talk fraction between the different isotopes.  
Tissue blood flow was calculated by the reference sample method (26) and expressed as 
ml/min/100g of tissue.  Adequate mixing of the microspheres was verified for each injection by 
demonstrating a <15% difference in blood flows to the right and left kidneys.   
Experimental protocol.   After completion of the surgical procedures, anesthetized rats 
were allowed to stabilize for 60 min.  After the stabilization period, a 30 min control period was 
completed during which Tc was maintained at 38оC in all rats.  At the end of the control period, 
heating experiments were initiated in splenic-intact and splenic-denervated rats by increasing Tc 
at a rate of 0.1оC/min from 38 to 41оC (30 min) followed by a maintenance phase in which Tc 
was maintained at 41оC for an additional 90 min.  Increases in Tc were produced using a heat 
lamp (29-33).  Nonheated experiments were completed in splenic-intact and splenic-denervated 
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rats by maintaining Tc at 38оC for an additional 120 min beyond the initial 30 min control 
period.   Mean arterial pressure (MAP), HR, and SND were measured continuously during the 
control periods and the heating and nonheating protocols.  Splenic blood flow (BF) 
measurements were completed at the end of the control period and at 30 and 120 min of the 
heating and nonheating protocols in nonheated splenic-intact (n = 3), heated splenic-intact (n = 
5) and heated splenic-denervated (n = 4) rats.   
Spleens were collected at the end of each experiment (with the exception of those used in 
experiments analyzing splenic blood flow) for splenic cytokine gene expression analysis and 
stored at -80оC.  Gene array analysis was performed on spleens collected from four rats in each 
experimental group (nonheated splenic-intact, heated splenic-intact, and heated splenic-
denervated).  To validate the gene array results, TaqMan probe-based real-time RT-PCR analysis 
was performed on spleens used for gene array analysis (n = 4 for each group) and spleens from 
additional experiments in each group (nonheated splenic-intact, n = 2; heated splenic-intact, n = 
3; heated splenic-denervated, n = 3). 
RNA isolation.  Frozen spleens were homogenized in liquid nitrogen and the total RNA 
was isolated using the TRI Reagent RNA isolation kit according to the manufacturer’s protocol 
(Sigma Chemical Co., St.  Louis, MO).  RNA purity and concentration were determined 
spectrophotometrically by calculating the ratio between the absorbances at 260 nm and 280 nm.   
The absorbance ratio for all samples ranged between 1.8 and 2.0.  The quality of RNA for all 
samples was confirmed by resolving them on a 1.5% formaldehyde agarose gel (47).   
Gene array analysis.  Splenic cytokine gene expression was evaluated using a mouse 
inflammatory cytokine cDNA array system from Superarray Biosciences (Bethesda, MD) as 
reported earlier (44).  The cDNA array blot contained 23 inflammatory cytokine and chemokine 
 
 
 15
gene fragments spotted in duplicate wells.  In addition, β-actin and GAPDH were included as 
positive controls and pUC18 DNA was included as a negative control.  Biotin-labeled cDNA 
probes were synthesized from total RNA by reverse transcription using an RT-Labeling Kit 
(SuperArray Biosciences, Bethesda, MD).  The labeled probes were hybridized to gene-specific 
cDNA fragments spotted on the gene array membranes.  Membranes were washed to remove any 
unincorporated probe and incubated with alkaline phosphatase conjugated streptavidin (AP-
streptavidin).  Relative expression levels of specific genes were detected from signals generated by 
chemiluminescence from the alkaline phosphatase substrate, CDP-Star.  The luminizing blots were 
used to expose X-ray films and quantified by spot densitometry with the aid of AlphaEase v5.5 
software (Alpha Innotech, San Leandro, CA).  The relative gene expression levels were estimated 
by comparing the signal intensity of the target gene to the signal intensity derived from β-actin. 
Real-time RT-PCR analysis.  To validate the gene-array results, TaqMan® probe-based 
real-time RT-PCR analysis was performed.  Total RNA (2µg) was reverse-transcribed in a 20 µl 
volume containing 1 µM of oligo(dT) primers, 0.5 mM of each dNTP, 0.5 U/µl of RNase 
inhibitor and 0.2 U/µl of Omniscript Reverse Transcriptase (Qiagen, Valencia, CA) in RNase-
free water.  The reaction was carried out for 60 min at 37.0оC and the cDNA mixture was used 
for the real-time PCR analysis of specific cytokine gene expression. 
Gene-specific PCR primer pairs and a TaqMan® probe for growth regulated oncogene 1 
(GRO 1) was obtained from Applied Biosystems (Foster City, CA).  The primers and probes for 
β-actin, IL-6 and IL-1β genes were custom synthesized using published sequences (7, 38).  
TaqMan® probes were labeled with 6-carboxyfluorescin (FAM) as the reporter dye molecule at 
the 5' end and 6-carboxy-tetramethyl-rhodamine (TAMRA) as the quencher dye molecule at the 
3' end.  Real-time PCR reactions were performed with 2 µl of cDNA using Universal PCR 
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Master Mix (Applied Biosystems, Foster City, CA), containing 0.9 µM each of the forward and 
reverse primers and 0.25 µM TaqMan® probes in a 25 µl reaction.  Real-time PCR analysis was 
performed in a Smart Cycler (Cepheid, Sunnyvale, CA) with the following PCR conditions: one 
cycle each of 50оC for 2 min and 95оC for 5 min, followed by 45 cycles of 95оC for 15 seconds 
and 60оC for 1 min.    
The threshold cycle (Ct) value for each gene was defined as the PCR cycle at which the 
emitted fluorescence rose above a background level of fluorescence, i.e., 30 fluorescence units.  
Gene expression levels were calculated as fold change relative to the gene expression of 
nonheated splenic-intact rats.  The PCR amplification efficiencies of β-actin and the target genes 
were calculated using the following formula: PCR efficiency = (10(1/-S) – 1) where S is the slope 
(21).  The amplification efficiency was greater than 90% for all genes.  The comparative Ct 
method (2
-∆∆Ct
) was used to quantify the results obtained by real time RT-PCR (41).  Data were 
normalized by determining differences in Ct values between the target gene of interest and β-
actin, defined as ∆Ct (Ct of target gene – Ct of β-actin gene).  The fold change was calculated as 
2(SAvg∆Ct – CAvg∆Ct) where SAvg∆Ct – CAvg∆Ct is the difference between the sample (heated-
intact/heated-denervated/nonheated-denervated) ∆Ct and the control (nonheated intact) ∆Ct.   
For nonheated intact samples, ∆∆Ct equaled zero and 20 equaled one, so that the fold change in 
gene expression relative to the nonheated intact samples equaled one.   For the treated samples, 
evaluation of 2
-∆∆Ct was defined as the fold change in gene expression relative to nonheated 
intact samples. 
Data and statistical analysis.  Values are means ± SE.  Control values of SND were taken 
as 0%.  Statistical analysis of SND, MAP, HR and splenic BF responses were analyzed using 
analysis of variance techniques with a repeated-measures (ANOVA-R) design.  When a 
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significant F-ratio was demonstrated by the ANOVA-R, the appropriate post-hoc tests (simple 
effects, Least Significant Difference, Bonferroni, Student-Newman-Keuls) were applied to 
describe significant MAP, HR, splenic SND, and BF versus time of heating interactions. Results 
from gene array and RT-PCR analyses in heated and nonheated rats were compared using 
Student’s t-tests or Mann-Whitney tests.  The overall level of statistical significance was p < 
0.05.    
 
RESULTS  
SND, MAP and HR responses to WBH.   Figure 1 shows SND traces from three 
representative experiments (A, nonheated splenic-intact; B, heated splenic-intact; C, heated 
splenic-denervated).  Tc was maintained at 38оC during the control period in each rat.   In the 
nonheated splenic-intact rat (A), Tc was held constant at 38оC for 120 min after control and 
splenic SND was unchanged from control at 30 and 120 min.   In the heated splenic-intact rat 
(B), Tc was increased from 38 to 41оC during the first 30 min after control and was maintained 
at 41оC for an additional 90 min (120 min total heating time).  Splenic SND was increased from 
control during heating at 30 and 120 min in the splenic-intact rat (B).  In the heated splenic-
denervated rat (C), no measurable splenic SND was detected during control or heating (30 and 
120 min), although renal SND was increased during heating.  Renal SND was recorded in the 
splenic-denervated rat to demonstrate specificity in the denervation procedure.    
Figure 2 summarizes splenic SND (top), MAP (middle) and HR (bottom) responses in 
nonheated (n=4) and heated (n=4) splenic-intact rats and heated splenic-denervated (n=4) rats.   
In nonheated splenic-intact rats, Tc was held constant at 38оC for 150 min (30 min of control,  
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-30 to 0 min, and 120 min after control) and splenic SND, MAP and HR remained unchanged 
from control in these rats.  In heated splenic-intact and -denervated rats, Tc was increased from 
38 to 41оC during the first 30 min (0 to 30 min) after the control period (-30 to 0 min) and was 
maintained at 41оC for an additional 90 min (30 to 120 min).  During heating, splenic SND was 
increased significantly from control in splenic-intact rats and was undetectable in splenic-
denervated rats.  MAP was increased significantly from control during the first 60 min of heating 
in splenic-intact rats and during the first 30 min of heating in splenic-denervated rats.  HR was 
significantly increased from control during heating in splenic-intact and -denervated rats.   
Splenic BF responses to WBH.  Figure 3 summarizes splenic BF responses in nonheated 
splenic-intact (n=3), heated splenic-intact (n=5), and heated splenic-denervated (n=4) rats.  Tc 
was maintained at 38оC during a 30 min preheating control period (Control) in all rats.  In 
nonheated splenic-intact rats, Tc was held constant at 38оC for 120 min after the control period 
and splenic BF was unchanged from control values at 30 and 120 min following cessation of the 
control period.  In heated splenic-intact and splenic-denervated rats, Tc was increased from 38-
41оC during the first 30 min after control and was maintained at 41оC for an additional 90 min.  
Splenic BF in splenic-intact and splenic-denervated rats was significantly increased from 
preheating control values at 30 min of heating but decreased to control values in both groups of 
rats at 120 min of heating.  Splenic BF responses during heating did not differ between splenic-
intact and splenic-denervated rats.   
Gene array analysis of splenic gene expression responses to WBH.   Figure 4 shows 
splenic gene array results from three representative experiments (nonheated splenic-intact, left; 
heated splenic-intact, middle; heated splenic-denervated, right).  β-actin and GAPDH served as 
internal control genes.  Expression of IL-1β, IL-6, and GRO 1 genes was increased in the heated 
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splenic-intact rat (marked by broken lines) compared to the nonheated splenic-intact rat and 
heated splenic-denervated rat.  Expression of TGF-β1 (Transforming growth factor-β1), 
interleukin-2 (IL-2), and interleukin-16 (IL-16) was observed in each experiment but did not 
consistently differ between groups.     
Quantitative values relative to β-actin for splenic IL-1β, IL-6, GRO 1, TGF-β1, IL-2, and 
IL-16 mRNA expression in nonheated splenic-intact (n=4), heated splenic-intact (n=4), and 
heated splenic-denervated (n=4) rats are summarized in Figure 5.  Expression of IL-1β, IL-6, and 
GRO 1 genes was significantly higher in heated splenic-intact compared with nonheated splenic-
intact and heated splenic-denervated rats.  Expression of TGF-β1, IL-2, and IL-16 genes did not 
differ between groups. 
  Real-time RT-PCR analysis of splenic gene expression responses to WBH.  Real-time 
RT-PCR analysis was performed for four genes (β-actin, IL-1β, IL-6, and GRO 1) from three 
experimental groups of rats; nonheated splenic-intact, heated splenic-intact, and nonheated 
splenic-denervated.  Representative amplification plots are shown in Figure 6.  β-actin mRNA 
expression did not differ between groups.  As indicated by the lower Ct values (a reflection of 
increased mRNA levels), expression of IL-1β, IL-6 and GRO 1 mRNA was higher in the heated 
splenic-intact rats compared to nonheated splenic-intact and heated splenic-denervated rats.     
Ct values in heated splenic-intact rats for IL-1β, IL-6 and GRO 1 genes were significantly 
lower than those in nonheated splenic-intact and heated splenic-denervated rats (Table 1).  Ct 
values did not differ between nonheated splenic-intact and heated splenic-denervated rats (Table 
1).  When the Ct values were translated to fold change, mRNA expression of IL-1β (2.3 to 4.0 
fold), IL-6 (4.7 to 16.2), and GRO 1 (3.9 to 9.1 fold) was higher in heated splenic-intact rats 
(n=7) than in nonheated splenic-intact rats (n=6).  The fold change for mRNA expression of IL-
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1β (2.3 to 4.0 fold), IL-6 (2.7 to 9.4 fold), and GRO 1 (3.2 to 9.5 fold) was lower in heated 
splenic-denervated rats (n=7) compared to heated splenic-intact rats and did not differ between 
heated splenic-denervated and nonheated splenic-intact rats. 
The role of the sympathetic nervous system in regulation of splenic gene expression 
under basal conditions was determined by comparing gene expression responses in nonheated 
splenic-intact (n=6) and nonheated splenic-denervated rats (n=3).  Ct values for IL-1β 
(nonheated splenic-intact, 24.13 ± 0.45; nonheated splenic-denervatedt, 27.2±0.3) and GRO 1 
(nonheated splenic-intact, 29.51 ± 0.53, nonheated splenic-denervatedt, 31.0±0.6) were 
significantly higher in nonheated-denervated compared with nonheated-intact rats.   Ct values for 
β-actin (nonheated splenic-denervated, 19.29 ± 0.33; nonheated splenic-intact, 19.6±0.13) and 
IL-6 (nonheated splenic-denervated, 30.20 ± 0.44; nonheated splenic-intact, 31.1±0.4) did not 
differ between groups.  When the Ct values were translated to fold change, mRNA expression of 
IL-1β (5.2 to 8 fold) and GRO 1 (1.4 to 2.8 fold) was lower in nonheated splenic-denervated 
compared with nonheated splenic-intact rats.     
 
DISCUSSION 
We present three new findings concerning the effect of WBH on sympathetic-immune 
interactions in anesthetized rats.  First, splenic SND was increased during heating in splenic-
intact rats but remained unchanged in nonheated splenic-intact rats.  Second, splenic IL-1β, IL-6 
and GRO 1 mRNA expression was higher in heated than in nonheated splenic-intact rats.  Third, 
splenic IL-1β, IL-6, and GRO 1 mRNA expression was significantly less in heated splenic-
denervated rats than in heated splenic-intact rats, but did not differ between heated splenic-
denervated and nonheated splenic-intact rats.  The observed differences in splenic cytokine gene 
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expression to WBH between splenic-intact and splenic-denervated rats were not dependent on 
differences in splenic blood flow during heating in these groups of rats.  These results support 
the hypothesis that hyperthermia-induced activation of splenic SND enhances splenic cytokine 
gene expression. 
Changing the level of efferent sympathetic nerve activity is a primary strategy used by 
mammals to respond to acute physical stress.  WBH is an acute stressor that substantially 
changes the level of activity in efferent sympathetic nerves (10-13, 22, 27, 29-31, 33, 36, 50).  
Hyperthermia-induced changes in sympathetic outflow alter blood flow distribution profiles to 
enhance heat dissipation while maintaining arterial blood pressure and vital organ perfusion 
pressure.  In addition to the thermoregulatory and cardiovascular consequences of heating-
induced sympathoexcitation, the current results support a role for the sympathetic nervous 
system in immune regulation as demonstrated by the fact that the enhanced expression of splenic 
cytokine and chemokine genes in response to WBH was abrogated by splenic denervation.   
Because the sympathetic nervous system plays an important role in mediating 
cardiovascular responses to heating (30, 32, 37), differences in splenic gene expression to 
heating in splenic-intact and splenic-denervated rats may have resulted from altered splenic 
blood flow responses to heating after splenic denervation.  However, this was not the case in the 
present study as splenic blood flow responses to heating did not differ between splenic-intact and 
splenic-denervated rats.  As demonstrated in a series of studies by Rogausch et al. (53, 54, 55), 
splenic blood flow regulation in the rat involves complex mechanisms.  In this regard, the current 
study provides little insight concerning the role of the sympathetic nervous system in modulating 
splenic blood flow responses to WBH, however, the primary focus of the blood flow studies was 
not to discern mechanisms regulating splenic blood flow responses to heating.  Rather, we 
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wanted to assess whether heating-induced changes in splenic gene expression could be ascribed 
to substantial changes in blood flow to this organ following splenic sympathetic denervation.   
WBH has been used in experimental settings as an adjunct to cytotoxic therapy in the 
treatment of various malignant diseases and it is hypothesized that the beneficial effect of WBH 
in these conditions may relate to heating-induced expression of cytokines (23, 28, 52).  The 
current finding that hyperthermia-induced increases in splenic IL-1β, IL-6 and GRO 1 mRNA 
expression were abrogated in splenic-denervated rats suggests that splenic sympathoexcitation to 
acute heating may contribute to the induction of cytokines observed during chemotherapy plus 
WBH protocols.  Consistent with this idea, Thyagarajan et al.  (60) reported reduced splenic 
norepinephrine concentrations, splenic IL-2 and interferon-gamma levels, and hypothalamic 
dopaminergic activity in saline-treated, mammary tumor-bearing rats.  In contrast, administration 
of L-deprenyl (a monoamine oxidase inhibitor) to rats with mammary tumors was associated 
with tumor regression, enhanced splenic production of IL-2, interferon-gamma, and natural killer 
cell activity, increased splenic norepinephrine concentrations, and increased hypothalamic 
dopaminergic activity.  These findings demonstrate interactions between the sympathetic 
nervous system and splenic immune function and suggest that increased central and peripheral 
catecholaminergic activity produced by deprenyl administration may enhance anti-tumor 
immunity (60).    
 The physiological relevance of the enhanced expression of splenic IL-1β, IL-6, and GRO 
1 genes to WBH is presently unknown, although numerous functional effects of these molecules 
have been established.  For example, IL-1β is a proinfammatory cytokine that induces 
lymphocyte proliferation, fever, and production of other cytokines (6, 62).   IL-6 is a 
multifunctional cytokine that is considered a factor in hematopoietic colony stimulation (63), 
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cytolytic T lymphocyte differentiation (49, 59), B cell differentiation (24), and T cell activation 
(24).   In addition, IL-6 is involved in the acute phase reaction (9, 40) and hematopoiesis (61) 
and has been shown to inhibit the growth and metastasis of autologous human cancers (59) and 
inhibit the growth of carcinoma cell lines (57).  GRO 1 is a growth-related oncogene and 
melanoma growth stimulatory factor and expression of the GRO family of genes is important in 
IL-1 induced inflammatory responses in fibroblasts (4).    
The current results are applicable to splenic tissue only and application to other lymphoid 
or secondary lymphoid organs remains to be established.  The current study used genomic level 
of analyses and may not represent the influence of WBH on splenic protein expression.  The 
present results provide insight concerning the role of splenic sympathetic nerves in splenic 
immune regulation in response to a specific experimental intervention (WBH) using an in vivo 
preparation and cannot necessarily be applied to other experimental interventions or 
preparations.  However, within the constraints of the current experimental protocols and 
analyses, the present results strongly support a role for splenic sympathetic nerves in increasing 
the expression of selective splenic cytokine genes in response to WBH.    
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Table 1. Threshold cycle (Ct) values for β-actin, IL-1β, IL-6, and GRO 1 genes from nonheated 
splenic-intact, heated splenic-intact, and heated splenic-denervated rats.    
 
 
 
 
 
 
 
 
 
 
 
Values are means ± SE.   nonheated intact (n=6), heated splenic-intact (n=7), heated splenic-
denervated (n=7).  * Significantly different from nonheated splenic-intact and heated splenic-
denervated rats. 
Genes Nonheated Heated Heated
Splenic-intact Splenic-intact Splenic-denervated
β-actin 19.29 ± 0.33  19.40 ± 0.31 19.66 ± 0.22
IL-1β 24.13 ± 0.45 22.34 ± 0.31* 24.45 ± 0.43
IL-6 30.20 ± 0.44 27.18 ± 1.07* 29.77 ± 0.37
GRO 1 29.51 ± 0.53 27.04 ± 0.67* 29.76 ± 0.76
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Figure 1. (A) Traces of splenic sympathetic nerve discharge (SND) recorded during control and 
at 30 min and 120 min after cessation of control in a nonheated rat with intact splenic nerves 
whose colonic temperature was maintained at 38°C.   (B)  Traces of splenic SND recorded before 
(Control) and during (30 min and 120 min) whole body heating that increased Tc from 38°C to 
41°C in a rat with intact splenic nerves.   (C)  Traces of splenic and renal SND recorded before 
(Control) and during (30 min and 120 min) whole body heating that increased Tc from 38°C to 
41°C in a splenic-denervated rat.    Horizontal calibration is 500 ms. 
Figure 1 
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Figure 2. Splenic sympathetic nerve discharge (SND), mean arterial pressure (MAP), and heart 
rate (HR) measurements in nonheated splenic-intact (filled squares), heated splenic-intact (open 
squares), and heated splenic-denervated (filled circles) rats.   Each group completed a 30 min 
control (-30 to 0 min) during which colonic temperature was held at 38°C.   Colonic temperature 
Figure 2 
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was maintained at 38°C for 120 min after cessation of control in nonheated splenic-intact rats.   
Colonic temperature was increased from 38°C to 41°C during the first 30 min after cessation of 
control and maintained at 41°C for an additional 90 min (120 min total heating time) in heated 
splenic-intact rats and heated splenic-denervated rats.  *Significantly different from control 
values. 
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Figure 3. Splenic blood flow measurements during control and at 30 and 120 min after cessation 
of control in: nonheated splenic-intact rats in which colonic temperature was maintained at 38ºC 
during and for 120 min after the control period, heated splenic-intact rats in which colonic 
temperature was increased from 38ºC to 41ºC during the first 30 min after control and was 
maintained at 41ºC for an additional 90 min (120 min total heating time), and heated splenic-
denervated rats that completed a similar heating protocol as described for heated splenic-intact 
rats.  * Significantly different from preheating control for heated splenic-intact and heated 
splenic-denervated rats.   
Figure 3 
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Figure 4. Gene array analysis for inflammatory cytokine gene expression.  Gene array analysis 
was performed on splenic mRNAs using cDNA array blots containing 23 inflammatory 
cytokines, chemokines, and housekeeping genes.   Array results for nonheated and heated 
splenic-intact rats and heated splenic-denervated rats are shown.   β-actin and GAPDH served as 
controls for normalizing mRNA for each experimental group.  Genes for which detectable 
changes in the mRNA expression levels were observed are shown as boxed wells.  The broken-
lined boxes in mRNA analyzed from the heated splenic-intact rat indicate the increase in the 
detected mRNA levels compared to the nonheated splenic-intact rat and the heated splenic-
Figure 4 
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denervated rat (shown as the solid-lined boxes).  A grid identifying each of the 23 inflammatory 
cytokines, chemokines, and housekeeping genes is shown below the individual arrays. 
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Figure 5. Quantitative values of mRNA expression levels of IL-1β, IL-6, GRO 1, TGF-β1, IL-2, 
and IL-16 were determined in nonheated splenic-intact (black bars), heated splenic-intact (gray 
bars) and heated splenic-denervated (white bars) rats.   Gene expression levels are presented 
relative to β-actin mRNA expression.  *Heated splenic-intact rats significantly different from 
nonheated splenic-intact and heated splenic-denervated rats.    
 
 
 
 
 
 
Figure 5 
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Figure 6. Real time RT-PCR analysis was performed for β-actin, IL-1β, IL-6, and GRO 1 and the amplification plots of representative 
experiments from three groups of rats (nonheated splenic-intact; heated splenic-intact; heated splenic-denervated) are shown.  A 
negative RT control (-veRT) for each primer set is also presented.    
Figure 6 
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ABSTRACT  
 
We tested the hypothesis that central angiotensin II (Ang II) administration would 
activate splenic sympathetic nerve discharge (SND) which in turn would alter splenic cytokine 
gene expression. Experiments were completed in sinoaortic-denervated, urethane-chloralose 
anesthetized, splenic nerve-intact and splenic nerve-denervated, Sprague-Dawley rats. Splenic 
cytokine gene expression was determined using genearray and real-time RT-PCR analyses. 
Splenic SND was significantly increased after intracerebroventricular (icv) administration of 
Ang II (150 ng/kg, 10 µl), but not artificial cerebrospinal fluid (aCSF). Splenic mRNA 
expression of IL-1β, IL-6, IL-2, and IL-16 genes was increased in Ang II-treated splenic-intact 
rats compared with aCSF-treated splenic-intact rats. Splenic IL-1β, IL-2, and IL-6 gene 
expression responses to Ang II were significantly reduced in splenic-denervated compared with 
splenic-intact rats. Splenic gene expression responses did not differ significantly in Ang II-
treated splenic-denervated and aCSF-treated splenic-intact rats. Splenic blood flow responses to 
icv Ang II administration did not differ between splenic-intact and splenic-denervated rats. These 
results provide experimental support for the hypothesis that Ang II modulates the immune 
system through activation of splenic SND, suggesting a novel relationship between Ang II, 
efferent sympathetic nerve outflow, and splenic cytokine gene expression.  
 
Key words:  Angiotensin II; splenic sympathetic nerve discharge; splenic cytokine gene 
expression 
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INTRODUCTION 
Bidirectional communication pathways exist between the central nervous system and the 
immune system (1, 2), and the sympathetic nervous system is considered an important 
component of the efferent arm mediating interactions between these systems (12). For example, 
the sympathetic innervation of the spleen provides a direct link between central sympathetic 
neural circuits and immunocompetent cells in the spleen (13,14), and changes in the level of 
efferent splenic sympathetic nerve discharge (SND) can alter immune responses in this organ 
(17).   
Angiotensin II (Ang II) is an octapeptide that is known to be involved in central regulation 
of cardiovascular function and sympathetic nerve outflow (4, 8, 37, 48, 54, 57).  Ang II type-1 
(AT1) receptors are found in areas of the brain associated with cardiovascular and autonomic 
regulation (39),  intracerebroventricular (icv) administration of Ang II increases renal and splenic 
SND (8, 54), and microinjection of Ang II into the rostral ventral lateral medulla (4, 48), 
paraventricular nucleus of the hypothalamus (57), and pontine A5 region (37) increases renal 
SND.  Central Ang II influences a diverse array of physiological responses (11, 22, 26, 27, 53), 
including immune responses to central administration of lipopolysaccharide (49).  ICV 
administration of an angiotensin converting enzyme inhibitor or an AT1 receptor antagonist 
attenuates brain IL-1β and febrile responses to icv administration of lipopolysaccharide (49), 
suggesting a link between brain Ang II and the immune system.  However, the influence of Ang 
II-induced activation of splenic SND on splenic immune function remains poorly defined.  
In the present study we determined the effect of icv (lateral ventricle) administration of 
Ang II on splenic SND and splenic cytokine gene expression in urethane-chloralose anesthetized 
rats. Because the sympathetic innervation of the spleen provides a direct link between central 
sympathetic neural circuits and splenic immune cells (13, 14), we hypothesized that central Ang 
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II administration would activate splenic SND which in turn would alter splenic cytokine gene 
expression as determined using genearray and real-time RT-PCR analyses.  Experiments were 
completed in splenic nerve-intact (splenic-intact) and splenic nerve-denervated (splenic-
denervated) rats.  
 
METHODS 
General procedures.  The Institutional Animal Care and Use Committee approved the 
experimental procedures and protocols used in the present study and all procedures were 
performed in accordance with the American Physiological Society’s guiding principles for 
research involving animals (3). Experiments were performed on Sprague-Dawley rats (368±5 g, 
n=50) anesthetized with isoflurane (during surgical procedures only; 3% induction followed by 
1.5%-2.5%), α-chloralose (initial dose 80 mg/kg ip, maintenance dose of 35-45 mg/kg/hr iv), and 
urethane (800 mg/kg ip).  The trachea was cannulated with a polyethylene-240 catheter and 
femoral arterial pressure was monitored using a pressure transducer connected to a blood 
pressure analyzer. Colonic temperature was maintained between 37.8°C and 38.0ºC by a 
homeothermic blanket.   
Arterial baroreceptors were denervated by cutting the superior laryngeal nerve near its 
junction with the vagus nerve, removing the superior cervical ganglion, and removing the 
adventitia from the carotid sinus bifurcation (31).  Sinoaortic denervation was considered 
complete by demonstrating loss of coherence between the arterial pulse and SND (23, 29).  
Studies were completed in sinoaortic-denervated rats to eliminate the influence of baroreceptor 
afferent feedback mechanisms that may attenuate SND responses of central origin.   
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A lateral ventricular cannula was surgically implanted after placing the rat in a stereotaxic 
frame, leveling the head between lambda and bregma, and making a small hole in the skull (1.2-
1.4 mm lateral to the midline and 0.8-1.0 mm posterior to bregma). A stainless steel guide 
cannula (22 gauge) was lowered 4 mm below the surface of the skull and an injector was 
introduced through the guide cannula to protrude 0.5 mm beyond the tip of the guide cannula. 
Neural recordings.  Splenic SND was recorded biphasically with a platinum bipolar 
electrode after preamplification (bandpass 30-3,000 Hz). In splenic-denervated rats, renal SND 
was recorded using similar recording and preamplification procedures. Splenic and renal 
sympathetic nerves were isolated from a lateral approach.  For monitoring during the experiment 
and for subsequent data analysis, the filtered neurograms were routed to an oscilloscope and a 
nerve traffic analyzer. Sympathetic nerve potentials were full-wave rectified, integrated (time 
constant 10 ms) and quantified as volts x seconds (V·s) (17, 29).  SND was corrected for 
background noise after administration of the ganglionic blocker, trimethaphan camsylate (10-15 
mg/kg iv). 
 
Splenic denervation.  A two step splenic denervation procedure was performed. Initially, 
the splenic bundle (including splenic artery, vein and nerve) was visualized and the splenic nerve 
was dissected free of surrounding connective tissue and sectioned at the base of the bundle. 
Subsequently, the individual arteries projecting to the spleen were identified and the sympathetic 
nerve adjoining each vessel was sectioned.  Denervation was considered complete when splenic 
nerve recordings completed after denervation demonstrated no sympathetic nerve activity. 
Splenic and renal blood flow determination using microspheres.  Catheters were placed 
in the right carotid artery and the femoral artery. The right carotid artery catheter was advanced 
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towards the heart and secured in position just inside the aortic arch. The femoral artery catheter 
was advanced towards the descending aorta and secured in place. The carotid catheter was 
connected to a pressure transducer and the femoral artery catheter was connected to a 1 ml 
syringe placed in a Harvard withdrawal pump. For each blood flow determination, blood 
withdrawal from the femoral artery catheter was initiated at a rate of 0.25 ml/min. At the same 
time, arterial blood pressure was recorded from the carotid artery catheter. After 30 seconds of 
blood withdrawal, the carotid artery catheter was disconnected from the pressure transducer and 
radioactive microspheres were injected into the aortic arch. Labeled microspheres were 15±3 µm 
in diameter. The microspheres were suspended in normal saline containing 0.01% Tween 80 
with a specific activity ranging from 7-15 mCi/g.  Before each injection, the microspheres, 6-7 x 
105 were thoroughly mixed and agitated by sonication.  Microspheres were injected into the 
ascending aorta in a volume of approximately 0.10 ml and the different radioactive labels (46Sc, 
85Sr, and 141Ce) were used in random order.  
Spleens and kidneys were removed, blotted, weighed and placed immediately into counting 
vials. The radioactivity of tissue samples was determined on a Packard Cobra II Auto-Gamma 
Spectrometer set to record the peak energy activity of each isotope for 5 min, and analyzed by 
computer, taking into account the cross-talk fraction between the different isotopes. Tissue blood 
flow was calculated by the reference sample method (25) and expressed as ml/min/100g of 
tissue. Adequate mixing of the microspheres was verified for each injection by demonstrating no 
significant difference in blood flows to the right and left kidneys. 
Determination of splenic artery blood velocity.  A Doppler flow probe filled with ultrasonic 
transmission gel was placed on the splenic artery for measurement of splenic blood flow velocity 
(30). The flow probe wires were connected to a pulsed Doppler flowmeter.  Details of the 
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Doppler technique, including the reliability of the method for estimation of velocity have been 
described previously (21).  Blood velocity (in kHz Doppler shift) is directly proportional to 
absolute blood flow, therefore the Doppler technique provides a relative measure of changes in 
flow (21).  
Central administration of Ang II and artificial cerebrospinal fluid (aCSF).  Lateral 
ventricle infusions were completed using an injector that was connected via polyethylene tubing 
to a 100 µl microsyringe driven by a micropump (1 µl/min, 10 min). Three experimental groups 
were completed; rats with intact splenic nerves that received icv infusions of aCSF (aCSF-
treated, splenic-intact), rats with intact splenic nerves that received icv infusions of Ang II (Ang 
II-treated, splenic-Intact), and splenic-denervated rats that received icv infusions of Ang II (Ang 
II-treated, splenic-denervated). After completion of the lateral ventricular cannulation and nerve-
electrode preparations, animals were allowed to stabilize for 60 min.  Measurements of SND, 
mean arterial pressure (MAP) and heart rate completed at the end of this stabilization period 
were considered as control data (-10 min in Figure 2). Following collection of control data, rats 
were treated with icv infusions (10 min) of aCSF (10 µl) or Ang II (150 ng/kg, 10 µl) and SND, 
MAP and heart rate recordings were made continuously for 60 min after cessation of icv 
infusions.  At the end of each experiment, spleens were collected (with the exception of those 
used in experiments analyzing splenic blood flow) for splenic cytokine gene expression analysis 
and stored at -80оC.  Gene array analysis was performed on spleens collected from aCSF-treated 
splenic-intact (n=3), Ang II-treated splenic-intact (n=5), and Ang II-treated splenic-denervated 
(n=3) rats.  TaqMan probe-based real-time RT-PCR analysis was performed on spleens used for 
gene array analysis and spleens from additional experiments in each group (aCSF-treated 
splenic-intact, n=3; Ang II-treated splenic-intact, n=3; Ang II-treated splenic-denervated, n=5). 
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RNA isolation. Frozen spleens were homogenized in liquid nitrogen and total RNA was 
isolated using the TRI Reagent RNA isolation kit according to the manufacturer’s protocol 
(Sigma Chemical Co., St. Louis, MO). RNA purity and concentration were determined 
spectrophoto-metrically by calculating the ratio between the absorbance at 260 nm and 280 nm 
using a NanoDrop ND-1000 (NanoDrop, USA). The absorbance ratio for all samples ranged 
between 1.8 and 2.0. The quality of RNA for all samples was confirmed by resolving them on a 
1.5% formaldehyde agarose gel (38). 
GeneArray analysis. Splenic cytokine gene expression was evaluated using a mouse 
inflammatory cytokine cDNA array system from Superarray Biosciences (Bethesda, MD) similar 
to a study reported earlier (17). The cDNA array blot contained 23 inflammatory cytokine and 
chemokine gene fragments (interleukin -1α, -1β, -2, -4, -5, -6, -10, -12α, -12β, -16, -17, -18; 
transforming growth factor -α, -β1, -β2, -β3;  interferon-γ;  growth regulated oncogene 1; 
lymphocyte toxin-β; macrophage inhibitory factor -1; monocyte chemoattractant protein -1; 
tumor necrosis factor-α, -β) spotted in duplicate wells. In addition, β-actin and GAPDH were 
included as positive controls and pUC18 DNA was included as a negative control. Biotin-labeled 
cDNA probes were synthesized from total RNA by reverse transcription using an RT-Labeling 
Kit (SuperArray Biosciences, Bethesda, MD). The labeled probes were hybridized to gene-
specific cDNA fragments spotted on the genearray membranes. Membranes were washed to 
remove any unincorporated probe and incubated with alkaline phosphatase conjugated 
streptavidin (AP-streptavidin). Relative expression levels of specific genes were detected from 
chemiluminescence signals generated after the addition of alkaline phosphatase substrate, CDP-
Star. The luminescent blots were used to expose X-ray films and the signal intensity of each spot 
was quantified by spot densitometry with the aid of AlphaEase v5.5 software (Alpha Innotech, 
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San Leandro, CA). The relative gene expression levels were estimated by comparing the spot 
density of the target gene to the spot density derived from β-actin. 
 
Real-time RT-PCR analysis. To validate the genearray results, TaqMan® probe-based 
real-time RT-PCR analysis was performed for a subset of genes. Total RNA (2 µg) was reverse-
transcribed in a 20 µl volume containing 1 µM of oligo(dT) primers, 0.5 mM of each dNTP, 0.5 
U/µl of RNase inhibitor, and 0.2 U/µl of Omniscript Reverse Transcriptase (Qiagen, Valencia, 
CA) in RNase-free water. The reaction was carried out for 60 min at 37ºC and the cDNA mixture 
was used for real-time PCR analysis. 
Gene-specific PCR primers and TaqMan® probe for TGF -β1 were obtained from 
Applied Biosystems (Foster City, CA). The primers and probes for β-actin, IL-1β, IL-6 and IL-2 
genes were custom synthesized using published sequences (6, 32) and the primers and probe for 
IL-16 were designed using the primer quest software (IDN technologies, Coralville, IA) with 
sense primer 5’AAATGGACACTGCCAATGG 
TGCTC3’, anti-sense primer 5’AAAGGAGCTGATTCTCTGCCGGAT3’, and probe 5’ 
AAGTCAGCAGATGGCAGC ACTGTGAA3’. TaqMan® probes were labeled with 6-
carboxyfluorescin (FAM) as the reporter dye molecule at the 5' end and 6-carboxytetramethyl-
rhodamine (TAMRA) as the quencher dye molecule at the 3' end. Real-time PCR reactions were 
performed with 2 µl of cDNA using Universal PCR Master Mix (Applied Biosystems, Foster 
City, CA), containing 0.9 µM each of the forward and reverse primers and 0.25 µM TaqMan® 
probes in a 25 µl reaction. Real-time PCR analysis was performed in a Smart Cycler (Cepheid, 
Sunnyvale, CA) with the following PCR conditions: one cycle each of 50ºC for 2 min and 95ºC 
for 5 min, followed by 45 cycles of 95ºC for 15 s and 60ºC for 1 min.  For IL-16 the real-time 
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PCR reaction was performed with 2 µl of cDNA using core reagent kit (Applied Biosystems, 
Foster City, CA) and the PCR conditions include one cycle each of 50ºC for 2 min and 95ºC for 
5 min, followed by 45 cycles of 95ºC for 30 s 58ºC for 30 s and 72ºC for 30 s. 
The threshold cycle (CT) value for each gene was defined as the PCR cycle at which the 
emitted fluorescence rose above a background level of fluorescence, i.e., 30 fluorescence units. 
Expression levels were calculated as fold change relative to the gene expression of aCSF-treated 
splenic-intact rats. The PCR amplification efficiencies of β-actin and the target genes were 
calculated using the following formula: PCR efficiency = 10(1/-S) – 1 where S is the slope (19). 
The amplification efficiency was estimated to be greater than 90% for all genes. The 
comparative CT method (2
-∆∆C
T) was used to quantify the results obtained by real time RT-PCR 
(35). Data were normalized by determining differences in CT values between the target gene of 
interest and β-actin, defined as ∆CT (CT of target gene – CT of β-actin gene). The fold change 
was calculated as 2(SAvg∆CT – CAvg∆CT) where SAvg∆CT – CAvg∆CT is the difference between the 
sample ∆CT (Ang II-treated splenic-intact or Ang II-treated splenic-denervated) and the control 
∆CT (aCSF-treated splenic-intact).  For aCSF-treated splenic-intact samples, ∆∆CT equaled zero 
and 20 equaled one, so that the fold change in gene expression relative to the aCSF-treated 
splenic-intact samples equaled one.  For the treated samples, evaluation of 2
-∆∆C
T was defined as 
fold change in gene expression relative to aCSF-treated samples. 
Brain histology.  At the end of each experiment fluorescent latex microspheres (50 nm 
diameter) were injected into the lateral ventricle, rats received an overdose of methohexital 
sodium (150 mg/kg, iv), and were transcardially perfused with 0.15 M NaCl (containing 3 IU/ml 
heparin) followed by a fixative solution consisting of 10% buffered neutral formalin (pH 7.4).  
Brains were removed, blocked, post-fixed in buffered neutral formalin, and placed in 20% 
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sucrose for cryoprotection. Brains were frozen sectioned at 40 µm in the coronal plane, collected 
into phosphate buffered saline, and mounted on slides in serial sequence. The sections were 
rinsed in distilled water, air dried, and cleared in xylenes. Lateral ventricular injection sites were 
confirmed by observing fluorescent microspheres in the ventricular system using brightfield or 
epifluoresence.  
Data and statistical analysis. Values are means ± SE. Splenic SND data are expressed as 
percentage change from baseline. SND, MAP and HR responses were analyzed using analysis of 
variance techniques with a repeated-measures design followed by Bonferroni post hoc tests. 
Results from genearray and RT-PCR analyses in aCSF-treated splenic-intact rats, Ang II-treated 
splenic-intact rats, and Ang II-treated splenic-denervated rats were compared using Student’s t-
tests or Mann-Whitney tests. The overall level of statistical significance was p<0.05. 
 
RESULTS  
SND, MAP and heart rate responses to icv Ang II or aCSF infusion.  Figure 7 shows SND 
traces recorded before (Control), immediately after and 60 min after icv Ang II infusion in a rat 
with intact splenic nerves (A) and in a splenic-denervated (B) rat. Splenic SND was increased 
from pretreatment levels immediately and 60 min after icv Ang II infusion in the rat with intact 
splenic nerves. No measurable splenic nerve activity was detected in the splenic-denervated rat, 
although, renal SND was increased after icv Ang II infusion (B).  Renal SND was recorded in 
splenic-denervated rats to demonstrate specificity in the denervation procedure.  
Figure 8 summarizes splenic SND, MAP, and heart rate responses in aCSF-treated splenic-
intact (n=6), Ang II-treated splenic-intact (n=8), and Ang II-treated splenic-denervated (n=8) 
rats.  Splenic SND, MAP, and heart rate remained unchanged from pretreatment levels (-10 min) 
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during (0 to 10 min) and after (10 to 70 min) icv aCSF infusion in splenic-intact rats. In Ang II-
treated splenic-intact rats, splenic SND, MAP and heart rate were increased significantly from 
pretreatment levels during and after icv Ang II infusion. In Ang II-treated splenic-denervated 
rats, no measurable splenic SND was recorded and MAP and heart rate were increased 
significantly from pretreatment levels during and after icv Ang II infusion.   Splenic SND was 
significantly higher in splenic-intact rats after Ang II infusion compared to after aCSF infusion.  
MAP did not differ between Ang II-treated splenic-intact and Ang II-treated splenic-denervated 
rats before, during, or after Ang II infusion.  MAP was significantly higher in splenic-intact and 
splenic-denervated rats during and after Ang II infusion compared to splenic-intact rats during 
and after aCSF infusion. 
Genearray analysis of splenic gene expression responses to icv Ang II or aCSF infusion. 
Genearray analysis was completed in aCSF-treated splenic-intact (n=3), Ang II-treated splenic-
intact (n=5), and Ang II-treated splenic-denervated (n=3) rats. Among the 23 cytokine genes, 
transcripts for IL-1β, IL-2, IL-6, IL-16, and TGF-β1 were consistently detected.  Expression of 
IL-1β, IL-2, and IL-16 genes was significantly higher in Ang II-treated splenic-intact rats 
compared to aCSF-treated splenic-intact and Ang II-treated splenic-denervated rats (Figure 9). 
IL-6 mRNA expression levels were significantly higher in Ang II-treated splenic-intact rats 
compared to Ang II-treated splenic-denervated rats but did not differ between Ang II-treated 
splenic-intact rats and aCSF-treated splenic-intact rats (Figure 3).  Expression of TGF-β1 did not 
differ significantly between groups (Figure 3). 
Real-time RT-PCR analysis of splenic gene expression responses to icv Ang II or aCSF 
infusion. Real-time RT-PCR analysis was performed to verify the genearray data and 
representative amplification plots are shown in Figure 10.  As indicated by the lower CT values 
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(a reflection of increased mRNA levels), expression of IL-1β, IL-2, IL-6, and IL-16 mRNA was 
higher in the Ang II-treated splenic-intact rat compared to the aCSF-treated splenic-intact and the 
Ang II-treated splenic-denervated rat. TGF-β1 and β-actin mRNA expression did not differ 
between groups. 
Table 2 summarizes mean absolute CT values for β-actin and mean corrected CT (∆ CT) values 
for 5 target genes from three experimental groups.  ∆CT values for IL-1β, IL-6 and IL-2 genes were 
significantly lower in Ang II-treated splenic-intact rats (n=8) compared with aCSF-treated splenic-
intact (n=6) and Ang II-treated splenic-denervated (n=8) rats (Table 2). The ∆CT value for IL-16 was 
significantly lower in Ang II-treated splenic-intact rats compared to aCSF-treated splenic-intact rats, 
but did not differ between Ang II-treated splenic-intact and Ang II-treated splenic-denervated rats 
(Table 2). ∆CT values for TGF-β1 did not differ between groups (Table 2).  When the CT values 
were translated to fold change, mRNA expression of IL-1β (2 to 11.3 fold), IL-6 (2.1 to 4.7 fold), IL-
2 (1.6 to 9.3 fold), and IL-16 (1.4 to 3.2 fold) was higher in Ang II-treated splenic-intact rats 
compared to aCSF-treated splenic-intact rats. The fold change for mRNA expression of IL-1β (1.7 to 
9 fold), IL-6 (3.2 to 7.3 fold), and IL-2 (1.4 to 8.4 fold), but not IL-16, was lower in Ang II-treated 
splenic-denervated rats compared to Ang II-treated splenic-intact rats, but did not differ between 
Ang II-treated splenic-denervated and aCSF-treated splenic-intact rats. 
The role of the sympathetic nervous system in regulation of splenic gene expression under 
basal conditions (no icv Ang II administration) was determined by comparing gene expression 
responses in aCSF-treated splenic-intact rats (n=6) and aCSF-treated splenic-denervated rats (n=3) 
using real-time RT-PCR. Mean absolute CT values for β-actin (aCSF splenic-intact, 15.87±0.17; 
aCSF splenic-denervated, 15.44±0.31) and mean corrected CT values for IL-1β (aCSF splenic-intact, 
7.76±0.87; aCSF splenic-denervated, 8.72±0.14), IL-6 (aCSF splenic-intact, 11.46±0.24; aCSF 
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splenic-denervated, 11.86±0.45), IL-2 (aCSF splenic-intact, 14.87±0.3; aCSF splenic-denervated, 
14.13±0.04), IL-16 (aCSF splenic-intact, 6.4±0.31; aCSF splenic-denervated, 7.39±0.36) and TGF-
β1 (aCSF splenic-intact, 3.31±0.28; aCSF splenic-denervated, 3.62±0.25) did not differ significantly 
between groups.     
Splenic blood flow responses.  Figure 11A summarizes splenic blood flow responses 
determined using microspheres in aCSF-treated (n=5) and Ang II-treated (n=7) splenic-intact 
rats, and Ang II-treated splenic-denervated (n=6) rats. Control levels of splenic blood flow did 
not differ significantly between groups. Splenic blood flow was not significantly changed from 
control levels immediately or 60 min after icv infusion of Ang II in splenic-intact or splenic-
denervated rats; however, splenic blood flow was significantly increased from control levels 60 
min after icv infusion of aCSF in splenic-intact rats.  Blood flow to the right and left kidneys did 
not differ in splenic-intact rats (Control: left kidney 667±82, right kidney, 646±89; Immediately 
after Ang II infusion: left kidney 515±65, right kidney, 547±51; 60 min after Ang II infusion: left 
kidney 431±67, right kidney, 439±66) or splenic-denervated rats (Control: left kidney 509±55, 
right kidney, 516±46; Immediately after Ang II infusion: left kidney 475±85, right kidney, 
482±79; 60 min after Ang II infusion: left kidney 456±79, right kidney, 435±67), demonstrating 
adequate mixing of microspheres during the experiments.  Renal blood flow (right and left 
kidneys) was significantly reduced 60 min after icv Ang II infusion in splenic-intact rats (see 
data in previous sentence) and tended (p>0.05) to be reduced 60 min after Ang II infusion in 
splenic-denervated rats (see data in previous sentence).   
In a separate group of experiments, splenic artery blood velocity was determined using 
Doppler flow probes to provide a continuous measure of relative blood flow before, during, and 
after icv Ang II infusion in splenic-intact (n=3) and splenic-denervated (n=3) rats.  Splenic blood 
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flow did not change significantly from control levels during or for 60 min after icv Ang II 
infusion in splenic-intact and splenic-denervated rats and did not differ between groups during or 
after Ang II infusion (Figure 11B). 
 
DISCUSSION  
This study determined the effect of central administration of Ang II on splenic cytokine 
gene expression in anesthetized, baroreceptor-denervated rats. The current results provide 
experimental support for three new findings that contribute to the understanding of the role of 
Ang II in mediating sympathetic-immune interactions. First, splenic SND was significantly 
increased after icv administration of Ang II, but not aCSF.  Second, splenic mRNA expression of 
IL-1β, IL-6, IL-2, and IL-16 was increased in Ang II-treated splenic-intact rats compared with 
aCSF-treated splenic-intact rats.  Third, splenic IL-1β, IL-2, and IL-6 gene expression responses 
to Ang II were significantly reduced in splenic-denervated compared with splenic-intact rats. 
These results suggest that central administration of Ang II activates splenic sympathetic nerve 
outflow, which in turn increases the expression of selective splenic cytokine genes. 
Bidirectional interactions between the nervous system and the immune system have been 
established (1, 2), and the sympathetic nervous system is thought to play a key role in mediating 
these interactions (12). The results of several studies demonstrate the central neural component 
of sympathetic-immune interactions (24, 28, 42, 51, 52). Icv infusion and hypothalamic 
microinjection of interferon-alpha reduce the cytotoxicity of splenic natural killer cells, an effect 
that is eliminated by splenic nerve denervation (51, 52). The cytotoxic activity of splenic natural 
killer cell activity is reduced after bilateral lesions of the medial part of the preoptic 
hypothalamus, an effect that is blocked by prior splenic denervation (28). Autonomic ganglionic 
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blockade, produced by intraperitoneal administration of chlorisondamine, antagonizes the 
immunosuppressive effect of centrally administered corticotrophin-releasing factor (24). 
Electrical stimulation of the ventromedial hypothalamus decreases the mitogenic response of 
splenic lymphocytes produced by concanavalin A administration, a response that is not observed 
in autonomic ganglion blocked or splenic nerve lesioned animals (42). The current study extends 
previous results by establishing a functional relationship between central Ang II administration, 
splenic nerve sympathoexcitation, and transcriptional regulation of splenic cytokine gene 
expression. Enhanced IL-1β, IL-2, and IL-6 splenic cytokine gene expression responses to 
central Ang II administration were observed in splenic-intact but not splenic-denervated rats, 
supporting a role for splenic sympathetic nerves in increasing the expression of selective splenic 
cytokine genes in response to central Ang II administration. Enhanced splenic cytokine gene 
expression responses were observed after central Ang II (increased splenic SND) but not central 
aCSF (no change in splenic SND) administration, suggesting that, under the conditions of the 
present experiments, activation of splenic sympathetic nerve outflow is required for upregulating 
the expression of selective splenic cytokine genes.  
It is known that Ang II influences regulation of the sympathetic nervous system and the 
immune system. With regards to the sympathetic nervous system, Ang II increases sympathetic 
nerve outflow after central and peripheral administration (43, 54, and the current results), 
influences the transcriptional regulation of genes for the norepinephrine transporter, tyrosine 
hydroxylase, and dopamine β-hydroxylase in the brain (18, 36, 55), and enhances the release of 
norepinephrine from noradrenergic nerve terminals through direct activation of the ganglion and 
prejunctional angiotensin receptors (9, 47).  Ang II modulates the immune system by augmenting 
the proliferation of splenic lymphocytes via a calcineurin pathway (41) and by increasing the 
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production of proinflammatory cytokines and transcription factors in the rat liver (5).  The 
current results provide experimental support for Ang II modulating the immune system through 
activation of efferent sympathetic nerve outflow, suggesting a novel relationship between Ang II, 
splenic sympathetic nerve discharge, and splenic cytokine gene expression. 
Because the central administration of Ang II increases splenic SND (54 and the current 
results), differences in splenic cytokine gene expression to icv Ang II infusion in splenic-intact 
and splenic-denervated rats may have resulted from altered splenic blood flow responses to Ang 
II after splenic denervation. This is likely not the case in the present study because splenic blood 
flow responses during and after Ang II infusion did not differ between splenic-intact and splenic-
denervated rats. In contrast to other visceral organs, little is known about the role of the 
sympathetic nervous system in regulation of splenic blood flow in the rat (44-46). Therefore, we 
can provide little insight concerning the role of splenic sympathetic activation in modulating 
splenic blood flow responses to central Ang II administration. However, the primary focus of the 
blood flow studies was not to discern mechanisms regulating splenic blood flow responses to 
Ang II, rather, we wanted to assess whether Ang II-induced changes in splenic cytokine gene 
expression could be ascribed to substantial changes in blood flow to this organ following splenic 
denervation. 
What is the functional significance of central Ang II-splenic SND-splenic cytokine gene 
expression interactions? Although the current results do not address this question, the 
pathophysiology of heart failure suggests an interesting possibility. Activation of the sympathetic 
nervous system is considered a hallmark of heart failure. Radiotracer studies of norepinephrine 
kinetics indicate increased norepinephrine spillover from the heart and kidneys (20, 40), 
microneurographic studies have demonstrated increased muscle SND in heart failure patients 
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(16, 33), and renal SND is significantly higher in animal models of cardiac failure than in 
noninfarcted controls (11, 15). The renin-angiotensin system is altered in heart failure. Icv 
injection of losartan decreases levels of resting renal SND in rats with chronic heart failure (11), 
and chronic central AT1 receptor blockade normalizes the enhanced sympathoexcitation, reduced 
sympathoinhibition, and desensitized baroreflex responses observed in congestive heart failure 
rats after myocardial infarction (56). Congestive heart failure patients exhibit clinical features 
that are observed in chronic inflammatory conditions (10, 34, 50). For example, plasma levels of 
proinflammatory cytokines, notably IL-6 and TNF-alpha, are elevated in congestive heart failure 
patients and serum levels of IL-10, a potent anti-inflammatory cytokine, are reduced (10, 34, 50). 
It is tempting to speculate that alterations in the central Ang II-splenic SND-splenic cytokine 
gene expression axis may play a role in the pathophysiology of congestive heart failure, 
providing rationale for understanding mechanisms mediating interactions between these different 
physiological systems. 
The current results are applicable to splenic tissue only, and their relevance to other 
primary and secondary lymphoid organs remains to be established. The genearray used in this 
study consists of a limited number of cytokine and chemokine genes, and the possibility exists 
that icv Ang II infusion regulates other cytokines, chemokines and their receptor genes. The 
present study utilized genomic level of analyses; therefore, the influence of icv Ang II infusion 
on splenic protein expression remains to be established.  Because protein appearance can be 
altered by numerous transcription- and translational-related events and, because little is known 
about the time required for protein synthesis to occur secondary to activation of splenic nerve 
efferents, we believe that determining the effect of central Ang II infusion on splenic protein 
synthesis is reasonably beyond the scope of the current study.   It must be considered that at least 
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part of the effect of central Ang II administration to influence splenic cytokine gene expression 
may have resulted from Ang II leaking from the cerebrospinal fluid into the peripheral 
circulation and causing norepineprine release from adrenergic nerve ending sites.  Although the 
current data do not exclude this possibility, it seems unlikely based on the results of Bruner et al. 
(7) who reported that plasma Ang II levels were not increased during the fifth day of a chronic 
icv infusion of Ang II administered in the microgram dose range.  In contrast, the present study 
used a single 10 min central infusion of Ang II administered in the nanogram dose range.  
Because Ang II can directly influence splenic immune cell function (5, 41), we did not complete 
peripheral control experiments in which Ang II was administered intravenously.   The current 
study was completed in sinoaortic-denervated rats to eliminate the influence of baroreceptor 
afferent feedback mechanisms that may attenuate SND responses of central origin; therefore, the 
influence of the arterial baroreflex on the functional relationship between Ang II, splenic 
sympathetic nerve discharge, and splenic cytokine gene expression remains to be established. 
 In summary, the current data provide insight concerning the role of splenic sympathetic 
nerves in splenic immune regulation in vivo to a specific experimental intervention (icv Ang II 
infusion) and, within the constraints of the current experimental protocol and analyses, the 
present results strongly support a role for splenic sympathetic nerves in increasing the expression 
of splenic cytokine genes in response to icv Ang II infusion. 
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Table 2. Corrected (∆CT) threshold cycle (CT) values for IL-1β, IL-6, IL-2, IL-16, and TGF-β1 genes from aCSF-treated splenic-
intact, Ang II-treated splenic-intact, and Ang II-treated splenic-denervated rats.  Absolute threshold cycle (CT) values for β-actin 
served as internal controls. 
 
Values are means ± SE.  ∆CT = Avg CT of target gene - Avg β-actin CT.  aCSF-treated splenic-intact  (n=6), Ang II-treated splenic-
intact (n=8), Ang II-treated splenic-denervated (n=8).  * Significantly different from aCSF-treated splenic-intact and Ang II-treated 
splenic-denervated rats.  † Significantly different from aCSF-treated splenic-intact rats.  
2.67±0.355.93±0.2914.72±0.2112.12±0.127.49±0.9515.47±0.19Ang II Splenic-denervated
3.03±0.35.36±0.2†12.93±0.5*9.81±0.2*5.51±0.4*15.84±0.1Ang II Splenic-intact
3.31±0.286.40±0.3114.87±0.3011.46±0.247.76±0.8715.87±0.17aCSF Splenic-intact
TGF-β1 ∆CTIL-16 ∆CTIL-2  ∆CTIL-6 ∆CTIL-1β ∆CTβ-actin CT
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Figure 7. (A) Traces of splenic sympathetic nerve discharge (SND) recorded before (Control), 
immediately after, and 60 min after cessation of icv Ang II infusion in a rat with intact splenic 
nerves. (B) Traces of splenic and renal SND recorded before (Control), immediately after, and 60 
min after cessation of icv Ang II infusion in a splenic-denervated rat. Horizontal calibration is 
500 ms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 
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Figure 8. .Splenic sympathetic nerve discharge (SND), mean arterial pressure (MAP), and heart 
rate measurements in aCSF-treated splenic-intact (filled circles), Ang II-treated splenic-intact 
Figure 8 
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(filled squares), and Ang II-treated splenic-denervated (open square) rats.  Measurements were 
obtained before (-10 min), during (0-10 min, indicated by horizontal bar), and for 60 min after 
(10-70 min) icv infusion of aCSF or Ang II.  * Significantly different from control values (-10 
min).  † Significantly different from aCSF splenic-intact rats. 
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Figure 9.  Levels of mRNA expression for IL-1β, IL-2, IL-6, IL-16, and TGF-β1 genes 
determined in aCSF-treated splenic-intact (black bars), Ang II-treated splenic-intact (gray bars), 
and Ang II-treated splenic-denervated (white bars) rats. Gene expression levels are presented 
relative to β-actin mRNA expression.  * Ang II-treated splenic-intact rats significantly different 
from aCSF-treated splenic-intact and Ang II-treated splenic-denervated rats. † Ang II-treated 
splenic-intact rats significantly different from Ang II-treated splenic-denervated rats. 
 
 
 
 
  
Figure 9 
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Figure 10.  Real time RT-PCR analysis was performed for β-actin, IL-1β, IL-6, IL-2, IL-16, and 
TGF- β1 and the amplification plots of representative experiments from three groups of rats 
(aCSF splenic-intact; Ang II splenic-intact; Ang II splenic-denervated) are shown. A negative 
RT control (-veRT) for each primer set is also presented.  
 
 
 
 
Figure 10 
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Figure 11.  (A) Splenic blood flow measurements during control (black bars), immediately after 
a 10 min infusion of aCSF or Ang II (gray bars), and 60 min after cessation of aCSF or Ang II 
Infusion (white bars) in splenic-intact and splenic-denervated rats.  * Significantly different from 
control values. (B)  Doppler splenic blood flow measurements in Ang II splenic-intact and Ang 
II splenic-denervated rats expressed as percent change from control levels (-10 min).  Continuous 
Figure 11 
 
 
 74
measurements were obtained before (-10-0 min), during (0-10 min), and for 60 min after (10-70 
min) icv infusion of Ang II.  
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ABSTRACT 
Splenic nerve denervation abrogates enhanced splenic cytokine gene expression 
responses to acute heating, demonstrating that hyperthermia-induced activation of splenic 
sympathetic nerve discharge (SND) increases splenic cytokine gene expression.  Hypothermia 
alters SND responses; however, the role of the sympathetic nervous system in mediating splenic 
cytokine gene expression responses to hypothermia is not known.  The purpose of the present 
study was to determine the effect of hypothermia on the relationship between the sympathetic 
nervous system and splenic cytokine gene expression in anesthetized F344 rats.  Gene expression 
analysis was performed using a microarray containing 112 genes representing inflammatory 
cytokines, chemokines, cytokine/chemokine receptors and housekeeping genes.  A subset of 
differentially expressed genes was verified by real-time RT-PCR analysis. Splenic SND was 
decreased significantly during cooling (core temperature decreased from 38 to 30ºC) in splenic-
intact rats but remained unchanged in sham-cooled splenic-intact rats (core temperature 
maintained at 38ºC). Hypothermia upregulated the transcripts of several genes including, 
chemokine ligands CCL2, CXCL2, CXCL10 and CCL20, and interleukins IL-1α, IL-1β and IL-
6.  Gene expression responses to hypothermia were similar for the majority of cytokine genes in 
splenic-intact and splenic-denervated rats. These results suggest that hypothermia-enhanced 
splenic cytokine gene expression is independent of splenic SND. 
 
Key words:  Hypothermia, splenic cytokine gene expression, splenic sympathetic nerve 
discharge. 
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INTRODUCTION 
Evidence from the disciplines of neuroscience and immunology demonstrate bidirectional 
communication pathways between the sympathetic nervous system and the immune system (2, 3, 
13, 38).  Sympathetic innervation to the spleen provides a connection between central 
sympathetic neural circuits and immunocompetent cells in the spleen (1, 6, 9, 16, 17).  For 
example, chemical sympathectomy alters splenic T and B cell proliferation and natural killer cell 
activity (36-40, 45) and diminishes splenic production of immunoglobulin M (31).  Results of 
our recent studies demonstrate that in rats with intact splenic nerves, whole body hyperthermia 
(19) and central angiotensin II infusion (20) increase splenic sympathetic nerve discharge (SND) 
and the expression of selective splenic cytokine genes.  Splenic cytokine gene expression 
responses to whole body hyperthermia and central angiotensin II infusion are significantly 
reduced in splenic nerve-denervated compared with splenic nerve-intact rats (19, 20), suggesting 
that activation of splenic SND can enhance splenic cytokine gene expression. 
Hypothermia, a common side effect of extreme cold environments, anesthesia, and 
serious traumatic injuries, alters the sympathetic nervous system and immune system regulation 
(8, 13-15, 21, 27-29, 47-50).  Acute cold stress increases plasma concentrations of 
norepinephrine and epinephrine (18, 26, 46, 52), changes the pattern of synchronized SND bursts 
(28), influences the frequency-domain relationships between discharge bursts in regionally 
selective sympathetic nerves (28), and produces nonuniform changes in the level of sympathetic 
nerve activity to selected target organs (28).  With regards to the latter, hypothermia increases 
lumbar and decreases renal SND without significantly changing the level of activity in the 
splanchnic and adrenal nerves in anesthetized rats (28) and activates preganglionic cervical SND 
in anesthetized rabbits (27).  Considering immune system regulation, hypothermia alters the 
activity of splenic natural killer cells (11, 25, 36), augments the production of inflammatory 
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cytokines in a cell line of peripheral blood monocytes (15), and increases cytokine gene 
expression in cultures of peripheral blood mononuclear cells (49).  In addition, plasma levels of 
proinflammatory cytokines are increased in patients suffering accidental hypothermia (4). 
Despite the substantial literature demonstrating that hypothermia alters regulation of the 
sympathetic nervous and immune systems, the influence of hypothermia on sympathetic-immune 
interactions is not well established for the following reasons.  First, the effect of hypothermia on 
splenic SND is not known.  Second, the effect of hypothermia on splenic cytokine gene 
expression is poorly understood.  Third, if hypothermia alters splenic cytokine gene expression, 
it is not known if this effect is dependent on the sympathetic innervation to the spleen.  In the 
present study we used splenic SND recordings, splenic nerve denervations, and splenic gene 
expression analyses (microarray and real-time RT-PCR) to determine the effect of hypothermia 
on the relationship between the sympathetic nervous system and splenic cytokine gene 
expression in urethane-chloralose anesthetized Fischer (F344) rats.  We tested the hypothesis that 
hypothermia would alter splenic SND thereby modifying the expression of selective splenic 
cytokine and chemokine genes. 
 
METHODS 
General procedures.  The Institutional Animal Care and Use Committee approved the 
experimental procedures and protocols used in the present study and all procedures were 
performed in accordance with the American Physiological Society’s guiding principles for 
research involving animals (5).  Experiments were performed on F344 rats (n=30) anesthetized 
with isoflurane (during surgical procedures only; 3% induction followed by 1.5%-2.5%), α-
chloralose (initial dose 80 mg/kg ip, maintenance dose of 35-45 mg/kg/hr iv), and urethane (800 
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mg/kg ip). The trachea was cannulated with a polyethylene-240 catheter and femoral arterial 
pressure was monitored using a pressure transducer connected to a blood pressure analyzer.  The 
pulsatile arterial pressure output of the blood pressure analyzer was used to derive heart rate.  
Colonic temperature (Tc) was maintained during surgical procedures between 37.8ºC and 38.0ºC 
by a homeothermic blanket. 
Neural recordings.  Following completion of the cannulation procedures, splenic and renal 
SND was recorded biphasically (bandpass 30-3000 Hz) with a platinum bipolar electrode after 
preamplification.  In splenic-denervated rats, renal SND was recorded using similar recording 
and preamplification procedures.  Splenic and renal sympathetic nerves were isolated from a 
lateral approach.  For monitoring during the experiment and for subsequent data analysis, the 
filtered neurograms were routed to an oscilloscope and a nerve traffic analyzer.  Sympathetic 
nerve potentials were full-wave rectified, integrated (time constant 10 ms) and quantified as volts 
x seconds (V·s) (19, 20, 28, 29).  SND was corrected for background noise after administration 
of the ganglionic blocker, trimethaphan camsylate (10-15 mg/kg iv). 
Splenic denervation.  A two-step splenic denervation procedure was performed.  Initially, 
the splenic bundle (including splenic artery, vein and nerve) was visualized and the splenic nerve 
was dissected free of surrounding connective tissue and sectioned at the base of the bundle. 
Subsequently, the individual arteries projecting to the spleen were identified and the sympathetic 
nerve adjoining each vessel was sectioned.  Denervation was considered complete when splenic 
nerve recordings completed after denervation demonstrated no sympathetic nerve activity. 
Experimental protocol.  After completion of the surgical procedures, chloralose-
anesthetized, gallamine-paralyzed, baroreceptor-innervated rats were allowed to stabilize for 60 
min.  After the stabilization period, a 30 min control period was completed during which Tc was 
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maintained at 38оC in all rats.  At the end of the control period, use of the homeothermic heating 
blanket was discontinued and ice packs were placed in close proximity to the dorsal and ventral 
surfaces of splenic-intact and splenic-denervated rats.  The rate of cooling was controlled by 
altering the position of the ice packs to maintain a reduction in Tc of 0.1°C/min from 38ºC to 
30ºC.  End-tidal CO2 was kept between 4.8 and 5.2% by adjusting the frequency of respiration 
during hypothermia. Sham-cooled experiments were completed in splenic-intact rats by 
maintaining Tc at 38ºC for an additional 80 min beyond the initial 30 min control period.  Mean 
arterial pressure (MAP), HR, and SND were measured continuously during the control periods 
and during the cooling and sham cooling protocols.  Spleens were collected at the end of each 
experiment and stored at -80ºC.  Gene array analysis was performed on spleens collected from 
four rats in each experimental group (Sham-cooled splenic-intact, cooled splenic-intact, and 
cooled splenic-denervated).  To validate the gene array results, TaqMan probe-based real-time 
RT-PCR analysis was performed on spleens used for gene array analysis (n = 4 for each group) 
and spleens from additional experiments in each group (sham cooled splenic-intact, n = 5; cooled 
splenic-intact, n = 8; cooled splenic-denervated, n = 5). 
RNA isolation.  Frozen spleens were homogenized in liquid nitrogen and total RNA was 
isolated using the TRI Reagent RNA isolation kit according to the manufacturer’s protocol 
(Sigma Chemical Co., St. Louis, MO).  RNA purity and concentration were determined 
spectrophoto-metrically by calculating the ratio between the absorbance at 260 nm and 280 nm 
using a NanoDrop ND-1000 (NanoDrop, USA). The absorbance ratio for all samples ranged 
between 1.8 and 2.0.  The quality of RNA for all samples was confirmed by resolving them on a 
1.5% formaldehyde agarose gel. 
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Microarray analysis.  Splenic cytokine gene expression was evaluated using a rat 
inflammatory cytokines and receptors microarray (Superarray Biosciences, Bethesda, MD).  The 
oligo/microarray blot contained 96 inflammatory cytokine and chemokine gene fragments with 
each gene spotted in four wells.  In addition, glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), ribosomal protein L32, lactate dehydrogenase A, aldolase A and biotinylated artificial 
sequence 2 complementary sequence were included as internal positive controls and PUC18 
plasmid DNA was included as an internal negative control.  Biotin-labeled cRNA probes were 
synthesized from total RNA TrueLabeling-AMPTM Linear RNA amplification kit (SuperArray 
Biosciences, Bethesda, MD).  The labeled cRNA probes were hybridized to oligonucleotide 
fragments spotted on the gene array membranes.  Membranes were washed to remove any 
unincorporated probe and incubated with alkaline phosphatase conjugated streptavidin (AP-
streptavidin).  Relative expression levels of specific genes were detected from signals generated by 
chemiluminescence from the alkaline phosphatase substrate, CDP-Star.  The luminizing blots were 
used to expose X-ray films and quantified by spot densitometry with the aid of GEArray 
expression analysis suite (Superarray Biosciences, Bethesda, MD).  The relative gene expression 
levels were estimated by comparing the signal intensity of the target gene to the signal intensity 
derived from GAPDH. 
Real-time RT-PCR analysis.  To validate the gene-array results, TaqMan® probe-based 
real-time RT-PCR analysis was performed.  Total RNA (2µg) was reverse-transcribed in a 20 µl 
volume containing 1 µM of oligo(dT) primers, 0.5 mM of each dNTP, 0.5 U/µl of RNase 
inhibitor and 0.2 U/µl of Omniscript Reverse Transcriptase (Qiagen, Valencia, CA) in RNase-
free water.  The reaction was carried out for 60 min at 37.0оC and the cDNA mixture was used 
for the real-time PCR analysis of specific cytokine gene expression. 
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Gene-specific PCR primer pairs and TaqMan® probes for chemokine (C-X-C motif) 
ligand 10 (CXCL10), chemokine (C-C motif) ligand 2 (CCL2), chemokine (C-X-C motif) ligand 
2 (CXCL2), chemokine (C-C motif) ligand 20 (CCL20) and, transforming growth factor beta 1 
induced transcript 4 (TGFβ1i4) were obtained from Applied Biosystems (Foster City, CA).  
Primers and probes for β-actin, lL-6 and IL-1β genes were custom synthesized using published 
sequences (7, 33).  TaqMan® probes were labeled with 6-carboxyfluorescin (FAM) as the 
reporter dye molecule at the 5' end and 6-carboxy-tetramethyl-rhodamine (TAMRA) as the 
quencher dye molecule at the 3' end.  Real-time PCR reactions were performed with 2 µl of 
cDNA using Universal PCR Master Mix (Applied Biosystems, Foster City, CA), containing 0.9 
µM each of the forward and reverse primers and 0.25 µM TaqMan® probe in a 25 µl reaction.  
Real-time PCR analysis was performed in a Smart Cycler (Cepheid, Sunnyvale, CA) with the 
following PCR conditions: one cycle each of 50оC for 2 min and 95оC for 5 min, followed by 45 
cycles of 95оC for 15 seconds and 60оC for 1 min. 
The threshold cycle (Ct) value for each gene was defined as the PCR cycle at which the 
emitted fluorescence rose above a background level of fluorescence, i.e., 30 fluorescence units.  
Gene expression levels were calculated as fold change relative to the gene expression of sham-
cooled splenic-intact rats.  The PCR amplification efficiencies of β-actin and the target genes 
were calculated using the following formula: PCR efficiency = (10(1/-S) – 1) where S is the slope 
(21).  The amplification efficiency was greater than 90% for all genes.  The comparative Ct 
method (2
-∆∆Ct
) was used to quantify the results obtained by real time RT-PCR (35).  Data were 
normalized by determining differences in Ct values between the target gene of interest and β-
actin, defined as ∆Ct (Ct of target gene – Ct of β-actin gene).  The fold change was calculated as 
2(SAvg∆Ct – CAvg∆Ct) where SAvg∆Ct – CAvg∆Ct is the difference between the sample (cooled-
 
 
 83
intact/cooled-denervated) ∆Ct and the control (sham-cooled intact) ∆Ct.  For sham-cooled intact 
samples, ∆∆Ct equaled zero and 20 equaled one, so that the fold change in gene expression 
relative to the sham-cooled intact samples equaled one.  For the treated samples, evaluation of 2
-
∆∆Ct was defined as the fold change in gene expression relative to sham-cooled splenic-intact 
samples. 
Determination of splenic artery blood velocity.  A Doppler flow probe filled with ultrasonic 
transmission gel was placed on the splenic artery for measurement of splenic blood flow velocity 
(32).  The flow probe wires were connected to a pulsed Doppler flowmeter.  Details of the 
Doppler technique, including the reliability of the method for estimation of velocity have been 
described previously (23).  Blood velocity (in kHz Doppler shift) is directly proportional to 
absolute blood flow, therefore the Doppler technique provides a relative measure of changes in 
flow (23).  
Data and statistical analysis.  Values are means ± SE.  Control values of SND were taken 
as 0%.  Statistical analysis of SND, MAP and HR were analyzed using analysis of variance 
techniques with a repeated-measures (ANOVA-R) design.  When a significant F-ratio was 
demonstrated by the ANOVA-R, post-hoc tests (Bonferroni) were applied to describe significant 
MAP, HR, splenic SND, and BF versus cooling interactions.  Results from gene array and RT-
PCR analyses in cooled and sham-cooled rats were compared using Student’s t-tests.  The 
overall level of statistical significance was p < 0.05.  
 
RESULTS 
SND, MAP and HR responses to hypothermia. Figure 12 shows SND traces from three 
representative experiments (A, sham-cooled splenic-intact; B, cooled splenic-intact; C, cooled 
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splenic-denervated).  Tc was maintained at 38ºC during the control period in each rat. In the 
sham-cooled splenic-intact rat (A), Tc was held constant at 38ºC after the control period and 
splenic SND remained unchanged from the control.  In the cooled splenic-intact rat (B), Tc was 
decreased from 38 to 30ºC and splenic SND was reduced from control during cooling.  In the 
cooled splenic-denervated rat (C), no measurable splenic SND was detected during the control 
period or cooling, although renal SND was decreased during cooling. Renal SND was recorded 
in the splenic-denervated rat to demonstrate specificity in the denervation procedure. 
Figure 13 summarizes splenic SND, MAP, and HR responses to hypothermia in splenic-
intact (n=7) and splenic-denervated (n=7) rats.  Tc was reduced from 38 to 30ºC at a rate of 
0.1ºC/1 min in both groups.  During cooling, splenic SND was decreased significantly from 
control (38ºC) in splenic-intact rats and was undetectable in splenic-denervated rats.  MAP and 
HR were progressively and significantly decreased from control (38ºC) during cooling in 
splenic-intact and splenic-denervated rats (asterisks denote statistically significantly reductions 
for MAP and HR in both groups).  Splenic SND was modestly but significantly increased 
whereas MAP and HR remained unchanged in sham-cooled (Tc held constant at 38ºC for 80 
min) splenic-intact rats (Table 3).  
 
Microarray analysis of splenic gene expression responses to hypothermia.  Figure 14 
shows microarray results performed with RNA isolated from spleens of three representative 
experiments (sham-cooled splenic-intact, left; cooled splenic-intact, middle; cooled splenic-
denervated, right). Expression of RPL32 and GAPDH genes (internal controls) was similar in 
each experiment. Expression of IL-1β, IL-6, CXCL2, CCL2 and CCL20 genes was increased in 
the cooled splenic-intact and splenic-denervated rats compared to the sham-cooled splenic-intact 
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rat.  Expression of CXCL10 was increased in the cooled splenic-intact rat compared with the 
sham-cooled splenic intact rat and the cooled splenic-denervated rat.  Expression of TGFβ1i4 
was observed in each experiment but did not differ between experiments. 
Values relative to GAPDH for splenic IL-1β, IL-6, CXCL10, CXCL2, CCL2, CCL20, 
TGFβ1i4 and RPL32 mRNA expression in sham-cooled splenic-intact (n=4), cooled splenic-
intact (n=4), and cooled splenic-denervated (n=4) rats are summarized in Figure 15.  Expression 
of IL-1β, IL-6, CXCL2, CCL2 and CCL20 genes was significantly increased in cooled splenic-
intact and cooled splenic-denervated rats compared to sham-cooled splenic-intact rats.  CXCL10 
gene expression was increased in cooled splenic-intact rats compared with cooled splenic-
denervated and sham-cooled splenic-intact rats.  Expression of TGFβ1i4 and RPL32 genes did 
not differ between groups. 
 
Real-time RT-PCR analysis of splenic cytokine gene expression responses to 
hypothermia.  Real-time RT-PCR analysis was performed for all candidate genes identified using 
microarray analysis (IL-1β, IL-6, CXCL10, CXCL2, CCL2, CCL20 and TGFβ1i4) from three 
experimental groups of rats; sham-cooled splenic-intact, cooled splenic-intact, and cooled 
splenic-denervated.  β-actin was used as the internal control gene.  Amplification plots for eight 
representative genes are shown in Figure 16.  β-actin mRNA expression did not differ between 
groups.  As indicated by the lower Ct values (a reflection of increased mRNA levels), expression 
of IL-1β, IL-6, CXCL2, CCL2, and CCL20 mRNA was higher in the cooled splenic-intact and 
splenic-denervated rats compared to sham-cooled splenic-intact rat.  The expression of TGFβ1i4 
did not differ between groups and the expression of CXCL10 was higher in the cooled splenic-
intact rat compared to the sham-cooled splenic-intact and cooled splenic-denervated rats.    
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Summarized real-time RT-PCR data are shown in Table 4.  The ∆Ct values were 
significantly lower (a reflection of increased mRNA levels) in cooled splenic-intact and cooled 
splenic-denervated rats for IL-1β, IL-6, CXCL2, CCL2 and CCL20 genes compared to sham-
cooled splenic-intact rats.  The ∆Ct value for TGFβ1i4 did not differ significantly between the 
groups and the ∆Ct for CXCL10 was significantly lower in cooled splenic-intact compared to 
sham-cooled splenic-intact rats, but not with cooled splenic-denervated rats.  When the Ct values 
were expressed as fold change, mRNA expression of IL-1β, IL-6, CXCL2, CCL2 and, CCL20 
was increased in cooled splenic-intact rats (n=11) and cooled splenic-denervated rats (n=8) 
compared with sham-cooled splenic-intact rats (n=10).  The fold change for mRNA expression 
of CXCL10 was increased only in cooled splenic-intact rats compared with sham-cooled splenic-
intact rats. 
Splenic blood flow responses to hypothermia. Splenic blood flow responses to 
hypothermia were determined in splenic-intact (n=7) and splenic-denervated (n=5) rats.  Splenic 
artery conductance was significantly increased from control (38.0ºC) in cooled splenic-intact 
(34ºC, +48±12%; 30ºC, +38±12%) and cooled splenic-denervated rats (34ºC, +32±20%; 30ºC, 
+30±18%). Splenic blood flow conductance responses to hypothermia did not differ (p=0.13) in 
cooled splenic-intact and cooled splenic-denervated rats. 
 
DISCUSSION 
The current study provides experimental support for three new findings concerning the 
influence of hypothermia on sympathetic-immune interactions in anesthetized F344 rats.  First, 
hypothermia produced progressive and significant reductions in the level of splenic sympathetic 
nerve activity.  Second, expression of selective splenic cytokine and chemokine genes was 
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higher in cooled compared with sham-cooled splenic-intact rats.  Third, similar hypothermia-
induced increases in splenic cytokine gene expression were observed in splenic-intact and 
splenic-denervated rats.  These results demonstrate that hypothermia upregulates splenic 
cytokine gene expression, an effect that is not dependent on the sympathetic innervation to the 
spleen.  
Changing the level of activity in peripheral sympathetic nerves in response to 
environmental challenges, including hypothermia, is a primary strategy used by mammals to 
maintain physiological homeostasis.  Sabharwal (50) reported that whole body hypothermia 
reduces renal SND in anesthetized, cold-acclimated rats.  Broman et al (8) reported that, in the 
absence of muscle shivering, whole body hypothermia reduces renal SND in nonacclimated, 
anesthetized rats.  In contrast to hypothermia-induced renal sympathoinhibitory responses, Kaul 
et al. (27) observed that acute cold stress activates preganglionic cervical SND in anesthetized 
rabbits, suggesting that decreased internal body temperature may elicit nonuniform changes in 
the level of efferent sympathetic nerve activity.  Consistent with this idea, whole body 
hypothermia in nonacclimated, anesthetized, paralyzed rats increases lumbar and decreases renal 
SND without significantly changing the level of activity in splanchnic and adrenal nerves (28).  
These findings demonstrate nonuniform responses to acute cold stress in sympathetic nerves 
innervating visceral and peripheral targets (renal SND decreased and lumbar SND increased) and 
in sympathetic nerves innervating visceral targets (renal SND decreased and splanchnic SND 
unchanged).  Because the overall aim of the current study was to determine the effect of 
hypothermia on the relationship between splenic SND and splenic cytokine gene expression and 
because whole body hypothermia produces nonuniform visceral SND responses (28), the first 
objective was to determine the effect of acute cold stress on the level of splenic SND, which, to 
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the best of our knowledge, remained unknown.  The present findings demonstrate that 
hypothermia in anesthetized rats produces progressive and significant reductions in the level of 
splenic sympathetic nerve activity, supporting the idea that hypothermia substantially alters 
efferent sympathetic nerve outflow. 
In recent studies we found that whole-body hyperthermia and central angiotensin II 
infusion increased both the level of splenic sympathetic nerve activity and the expression of 
selective splenic cytokine and chemokine genes (19, 20).  The enhanced splenic gene expression 
to these interventions was abrogated by denervation of splenic sympathetic nerves, suggesting a 
role for splenic sympathoexcitation in upregulation of selective splenic cytokine genes.  Based 
on these findings, we reasoned that splenic sympathoinhibitory responses to hypothermia would 
reduce the expression of selective splenic cytokine and chemokine genes.  However, the present 
findings show enhanced splenic cytokine and chemokine gene expression responses to 
hypothermia, despite concomitant splenic sympathoinhibition.  In addition, splenic gene 
expression responses to hypothermia, with the exception of CXCL10, were similar in splenic 
nerve-intact and splenic nerve-denervated rats, indicating that changes in splenic cytokine gene 
expression to acute cold stress in anesthetized, nonacclimated rats are independent of 
sympathetic innervation to the spleen. 
The results of previous studies (11, 14, 15, 25, 30, 36, 47, 49) indicate that hypothermia 
alters immune system regulation.  Moderate cooling (in vivo studies) increases natural killer cell 
activity (11, 34), white blood cell counts, (24) and monocytic expression of IL-6 and TNF-α (11) 
in human subjects.  In vitro studies using human cell lines incubated at 32ºC and 33ºC showed 
increased IL-10 and decreased interferon gamma cytokine gene expression in peripheral blood 
cultures (49), decreased production of IL-10 in peripheral mononuclear blood cells (41), and 
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prolonged activation of nuclear factor kappa B and increased proinflammatory cytokine gene 
expression in lipopolysaccharide-treated human monocytic cell lines (15).  In addition, cold 
exposure has been shown to suppress T-lymphocyte proliferation and splenic natural killer cell 
activity in rodents (25, 30).  The current study used a broad scale experimental approach, 
involving microarray and real-time PCR analyses, to determine the effect of whole-body cooling 
on splenic cytokine, chemokine, and receptor genes in anesthetized rats.  Hypothermia 
significantly enhanced the splenic expression of IL-1β, IL-6, CXCL2, CXCL10, CCL2 and 
CCL20 mRNA.  IL-1β mediates proinflammatory immune responses (12), IL-6 is a 
multifunctional cytokine that regulates the acute-phase response (10), CXCL2 is a macrophage 
inflammatory protein-2 (42, 43) and CCL20 is a macrophage inflammatory protein-3 (48), 
CXCL10 is a γ-interferon-inducible protein (44), and CCL2 is a monocyte chemoattractant 
protein (22).  Collectively, the current findings indicate that acute hypothermia upregulates the 
expression of a functionally diverse array of splenic cytokines and chemokines.     
One possible mechanism mediating hypothermia-induced increases in splenic cytokine 
and chemokine gene expression may be a direct effect of acute cooling on splenic immune cells. 
Consistent with this idea, the results of several studies demonstrate enhanced proinflammatory 
cytokine expression from immune cells cooled in vitro (15, 41, 49).  The present results 
demonstrate significant increases in splenic artery conductance during cooling in splenic nerve-
innervated and -denervated rats, suggesting that circulating factors may contribute to the 
enhanced gene expression observed in splenic tissue in response to hypothermia.  For example, 
cytokines released from activated peripheral monocytes or activated peripheral monocytes 
themselves could circulate to the spleen and enhance the expression of proinflammatory 
cytokines in this tissue.  Similarly, indirect activation of splenic immune cells via circulating 
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catecholamines may be involved because cold-stress increases plasma levels of catecholamines 
(18, 26, 46, 52), which in turn can activate α2-adrenergic receptors and enhance proinflammatory 
cytokine levels (51).  Because of this possibility, the present findings suggest that the 
upregulation of splenic cytokine gene expression to hypothermia under the conditions of the 
current experiments is not dependent on the sympathetic innervation to the spleen; however, an 
effect of the sympathetic nervous system via circulating catecholamines cannot be discounted. 
The current study is applicable to splenic tissue only, and the application to other 
lymphoid organs remains to be established.  Furthermore, because a pathway specific microarray 
with a limited number of cytokines and chemokines was used in the current study, the role of 
hypothermia on other immune parameters needs further examination.  The use of gene array and 
real-time RT-PCR analyses gives an estimate of the genomic levels of expression and may not 
represent protein expression in the spleen.  However, within the constraints of the current 
experimental protocols and analyses, the present results show that during core-body cooling 
splenic SND is decreased and splenic cytokine gene expression is increased and this enhanced 
splenic cytokine gene expression is independent of splenic sympathetic innervation.  
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Table 3. Splenic SND, MAP, and HR recorded in sham-cooled splenic-intact rats maintained at 
38ºC for 80 min. 
 
 
 
 
 
 
 
Values are mean ± SE; SND, sympathetic nerve discharge (n=5); MAP, mean arterial pressure 
(n=5); HR, heart rate (n=5); bpm, beats/min.  *Significantly different from control values 
(p<0.05). 
 
 
 
 
 
 
 
 
  
424±9426±9425±8424±8425±8423±7422±7418±8420±6HR (bpm)
109±5111±5112±5110±5111±5111±4111±5111±5113±4MAP (mmHg)
19±2*15±3*14±3*9±37±28±42±44±20SND   (%)          
80706050403020100Time (min)
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Table 4. Absolute Ct values and fold change from sham-cooled splenic intact rats for IL-1β, IL-
6, CXCL10, CXCL2, CCL2, CCL20 and, TGFβ1i4 genes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are means ± SE; ∆Ct = Avg Ct of target gene – Avg Ct of β-actin, 2-∆∆Ct = Fold change in 
gene expression relative to sham-cooled splenic-intact rats. 
*Cooled splenic-intact and cooled splenic-denervated rats significantly differ from sham-cooled 
splenic-intact rats (P<0.05).   
†Cooled-splenic-intact rats significantly differ from sham-cooled splenic-intact rats (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.0 (0.9 – 1.1)6.4 ± 0.21.1 (1 – 1.1)6.3 ± 0.046.4±0.1TGFβ1i4
7.5 (5.7 – 9.9)5.2 ± 0.3*10.0 (8.3 – 12)4.8 ± 0.3*8.1±0.6CCL20
6.1 (5.3 – 6.5)1.3 ± 0.1*5.5 (5.4 – 5.5)1.4 ± 0.1*3.9±0.6CCL2
16.1 ( 13 – 22)2.9 ± 0.4*13.9 (11 – 18)3.1 ± 0.4*6.9±0.8CXCL2
1.8 (1.4 – 2.1)1.9  ± 0.33.6 (1.5 – 2.2)0.9 ± 0.3†2.7±0.5CXCL10
13.0 (10 – 17)4.0 ± 0.4*14.4 (11 – 19)3.9 ± 0.4*7.7±0.6IL-6
2.1 (1.7 – 2.7)2.2 ± 0.3*2.5 (2.2 – 2.8)2.0 ± 0.2*3.3±0.3IL-1B
(2-∆∆Ct)(2-∆∆Ct)∆Ct
Fold change
∆ Ct
Fold change
∆Ct
Splenic-intact
Cooled Splenic-denervatedCooled Splenic-intactSham-cooled 
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Figure 12.  (A) Traces of splenic sympathetic nerve discharge (SND) recorded during control 
(38ºC) and during sham cooling in a splenic-intact rat in which internal body temperature (Tc) 
was maintained at 38ºC. (B) Traces of splenic SND recorded during control (38ºC) and during 
hypothermia (34ºC and 30ºC) in a splenic-intact rat.  (C) Traces of splenic and renal SND 
recorded during control and during hypothermia (34ºC and 30ºC) in a splenic-denervated rat.  
Horizontal calibration is 500 ms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 
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Figure 13.  Splenic sympathetic nerve discharge (SND), mean arterial pressure (MAP), and heart 
rate (HR) during control (38ºC) and hypothermia (Tc decreased from 38ºC to 30ºC) in splenic-
intact (open circles) and splenic-denervated (filled circles) rats.  *Cooled splenic-intact and 
cooled splenic-denervated rats significantly different (P<0.05) from control values. 
Figure 13 
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Figure 14. Microarray analysis of inflammatory cytokine gene expression.  Microarray analysis 
was performed on splenic mRNAs using cDNA array blots containing 112 inflammatory 
cytokines, chemokines, cytokine/chemokine receptors, and housekeeping genes.  Representative 
arrays from sham-cooled splenic-intact, cooled splenic-intact, and cooled splenic-denervated rats 
are shown.  GAPDH and RPL32 served as internal controls.  Genes for which detectable changes 
in mRNA expression were observed in cooled splenic-intact and cooled splenic-denervated rats 
compared with sham-cooled splenic-intact rats are indicated by the arrows, except for CXCL10 
whose gene expression was decreased in the cooled splenic-denervated rat marked by arrow. 
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Figure 15.  Values of mRNA expression levels of IL-1β, IL-6, CXCL10, CXCL2, CCL2, 
CCL20, TGFβ1i4, and RPL32 in sham-cooled splenic-intact (black bars), cooled splenic-intact 
(gray bars), and cooled splenic-denervated (white bars) rats.   Gene expression levels are 
presented relative to GAPDH mRNA expression.  *Cooled splenic-intact and cooled splenic-
denervated rats significantly different (P<0.05) from sham-cooled splenic-intact rats, †Cooled 
splenic-intact rats significantly different (P<0.05) from sham-cooled splenic-intact and cooled 
splenic-denervated rats. 
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Figure 16.  Real-time RT-PCR analysis was performed for β-actin, IL-1β, IL-6, CXCL10, 
CXCL2, CCL2, CCL20 and, TGFβ1i4 and the amplification plots of representative experiments 
from three groups of rats (Sham-cooled splenic-intact; Cooled splenic-intact; Cooled splenic-
Sham-Cooled
splenic-intact
Cooled
splenic-intact
Cooled
splenic-denervated
-veRTFigure 16 
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denervated) are shown. A negative RT control (-veRT) for each primer set is also presented. 
∆Rn; change in fluroscence. 
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SUMMARY 
 
Important bi-directional interactions exist between the central nervous system and the 
immune system. The sympathetic nervous system is considered an important componenet of the 
bi-directional neuro-immune interactions however, there is no direct evidence to demonstrate the 
modulatory role of the sympathetic nervous system in neuro-immune interactions. In the current 
studies we measured splenic nerve recordings and completed surgical splenic nerve denervations 
to demonstrate the role of splenic SND in splenic cytokine gene expression.  In the first study 
(chapter 1) we demonstrated that hyperthermia-enhanced splenic cytokine gene expression is 
dependent on heating induced splenic-sympathoexcitation, indicating a role for the sympathetic 
nervous system in modulating splenic cytokine gene expression.  In the second study (chapter 2) 
we demonstrated the role of central Ang II-induced increases in splenic SND in increasing 
splenic cytokine gene expression. These findings support the results from the first study 
demonstrating that enhanced splenic SND increases splenic cytokine gene expression.  In 
addition, splenic blood flow studies demonstrated that enhanced splenic cytokine gene 
expression to central activation is not dependent on changes in splenic blood flow. 
In the third study (chapter 3) the effect of acute cooling on splenic SND and splenic 
cytokine gene expression was determined. The results from this study showed that progressive 
hypothermia significantly decreased splenic SND and increased splenic cytokine gene expression 
in both splenic-intact and splenic-denervated rats, suggesting that hypothermia-induced increases 
in splenic cytokine gene expression is not dependent on splenic SND.  In this study hypothermia 
significantly decreased splenic SND, according to the results from the studies 1 & 2 we expected 
to see a decrease in the splenic cytokine gene expression, in contrast, we found a significant 
increase in the splenic cytokine gene expression in both splenic-inatct and splenic-denervated 
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rats. These findings demonstrate that the interactions between the sympathetic nervous system 
and the immune system are very complex and the modulatory role of SND on the immune 
system system is dependent on the type of stimulus.  
 
 
